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Abstract 
The evolution of multidrug resistant bacteria is one of the greatest challenges to modern medicine to 
date, with cases of multidrug resistant, untreatable Staphylococcus aureus being reported all over the 
globe. S. aureus is often transmitted across species through contact. Therefore, the importance of 
surveying potential populations becomes apparent, especially in dogs, which are often close with 
humans and can carry virulent forms of S. aureus asymptomatically. The aim of this project was to 
gauge the extent of S. aureus colonisation in dog populations that is otherwise overlooked. This project 
tested this in two parts: by detecting prevalence rates of S. aureus and its pathogenic factors (virulence 
and antibiotic resistance genes) due to human interaction; and testing the reliability of methods 
previously employed to carry out these types of prevalence studies. For prevalence testing, nasal swabs 
were taken from 113 dogs visiting a local Veterinary Hospital in Durban of which 35% (n = 40) were 
found to carry Methicillin Susceptible S. aureus (MSSA). No cases of Methicillin Resistant S. aureus 
(MRSA) were observed. Prevalence of virulence and antibiotic resistance genes were estimated using 
conventional PCR. Kirby-Bauer Disc diffusion was used to detect resistance to 9 classes of antibiotics. 
The most notable findings were 12.5% tetracycline resistance attributable to tetK and tetM; 15% of 
samples carried immune evasion clusters (IEC) carried by βC-ϕ’s; 7.5% of isolates were linezolid and 
vancomycin resistant (LR-VRSA) not attributable to resistance genes cfr and vanA respectively and 
were not induced by veterinary practices. This is of great concern as LR-VRSA has never been detected 
before in animals or outside of India and it is clear that some isolates are surviving beyond treatment, 
hidden in reservoir populations, like dogs. The Reliability of Methods tested if Mannitol Salt Agar 
(MSA) was sensitive and selectively powerful enough to isolate S. aureus from dog nasal swabs as 
compared to HiCromeTM Aureus Agar Base (AAB) which is suggested to be more suitable for 
environmental samples by the manufacturer. Fifty-six samples were collected and processed on both 
MSA and AAB media. Presumptive results were confirmed as S. aureus if the species-specific gene 
nuc was detected. Presumptive results from selective media and genomic confirmation of the nuc gene 
were compared to the true states of each sample so to measure the sensitivity, percentage of type I errors 
due to poor selective power and accuracy of true state prediction in conjunction with nuc testing of each 
media. MSA was 60.9%, 60%, and 84% respectively. AAB was 95.7%, 0% and 98.2% respectively. 
Odds ratios determined AAB as 14.08 times more likely to detect S. aureus from dog nare samples than 
MSA. This suggests that MSA is not suitable for the context of S. aureus isolation from dogs and that 
previous prevalence rates may be underestimated by as much as 60%. Both investigations demonstrated 
that dogs are a grossly under-represented reservoir population for S. aureus, both in prevalence and 
potential for disease.  
Keywords: Staphylococcus aureus; Antimicrobial Resistance; Virulence; Dogs; Selective Medium 
Comparative Analysis. 
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CHAPTER 1: GENERAL INTRODUCTION 
 
1.1. Background and Rationale 
Staphylococcus aureus is a Gram-positive coccus bacterium with no natural appendages that 
tends to group cells in grape like clusters (Harris et al., 2002). It replicates via binary fission 
(asexual reproduction) but progeny cells do not always separate completely from each other, 
causing them to cluster as they do. Colonies are usually a pale yellow to yellow colour (thus 
aureus, meaning gold in Latin) when grown on standard nutrient agar and will change the 
indicator dye in mannitol salt agar yellow (Ryan & Ray, 2004). It is a catalase positive and β-
haemolytic cocci (Matthews et al., 1997). It is a ubiqutous organism that can be both 
commensal (of no harm to its host) or pathogenic (disease causing) and will present in 80% of 
all humans throughout their lives (Kluytmans et al., 1997). In its virulent or pathogenic form, 
it can cause several diseases as a result of infection such as infective endocarditis (infection of 
the membrane lining the inside of the heart), osteoarticular infections (infection of joints), 
pleuropulmonary infections (infection of the membrane lining the lungs and thorax), infections 
of skin and soft tissue and also severe infections involving internalised devices such as 
catheters, IV drips and other devices (Kluytmans et al, 1997; Liu, 2009; Tong et al, 2015).  
Dogs have long since evolved alongside humans as companion animals for a few millennia 
(Thalmann et al., 2013). In the UK alone, 31% of households own at least one dog (Murray et 
al., 2010). No consensus data is available on this matter for South Africa, but dog ownership 
is not uncommon. This would then stand to reason that man and animal have been sharing the 
same environment and thus, the same pathogens, and they too have been evolving alongside 
man and dog. Opportunistic bacteria like Staphylococcus aureus, being ubiquitous to the types 
of environments people live in, are also found living on and in companion animals (and 
humans) as natural and unnatural flora (Jarraud et al., 2002). These types of non-target-species 
specific bacteria can be transmissible between companion animals and humans (Österlund et 
al., 1997). As it is understood that S. aureus is transmissible through contact (Jacobs, 2014; 
Koenig et al., 2016), more virulent forms of these bacteria can also be transmitted between 
people and companion animals.  
The domestication of these animals means that their population numbers are predominantly 
controlled by humans, for the most part, as a form of revenue for the breeder. However, with 
peoples’ poor forethought regarding the responsibility of caring for these animals there are 
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many companion animals that become stray or are born of other strays and do not receive the 
same medical upkeep as compared to some animals kept as pets would (Bartllett et al., 2005). 
As a result, this and the generally unhygienic environments (rural farms or unmaintained urban 
areas) and lack of care, these stray animals are often susceptible to being diseased. A common 
disease for many furred mammals is a skin condition commonly called mange (Fourie et al., 
2007). It is caused by tiny mites of varying genus’s that often naturally occur in the fur of these 
animals, but poor hygiene and lack of care (poor diet, lack of vaccinations, poor grooming 
practices) will compromise the animal’s immune system, causing the mite population to grow. 
The mites compromise the integrity of the skin and can cause small lesions and hair loss as 
they irritate the skin on the animal (Paradis, 1999). Commonly associated with mange is 
secondary infection by pyogenic bacteria, such as Staphylococcal species, including S. aureus 
(although not the most common Staphylococcal species), and others like Streptococcus 
pyogenes. These bacteria will colonise the compromised skin causing the formation of pus 
(thus pyogenic) and due to the already subdued immune system of the animal, are very difficult 
to remove from the animal without the aid of antibiotics (Shipstone, 2000). Unfortunately, 
antibiotic use, since they were first discovered and synthesised, have not been used responsibly 
(unnecessary prescription for non-bacterial causing illnesses and patients not completing 
treatment courses), both in humans and our pets, thus causing the rise in bacterial strains that 
are no longer susceptible to some antibiotics (Goossens et al., 2005; Lee Ventola, 2015). In the 
case of S. aureus, there is a great concern for methicillin resistant strains which are no longer 
susceptible to many penicillin-based antibiotics known as β-lactams (Lowy, 2003).  
Taking into cognizance the fact that this bacterium is opportunistic and can infect humans, 
there is always the risk that contact with a companion animal, especially one that is sick or 
diseased, may lead to an infection with antibiotic resistant forms of these bacteria in the human, 
especially if the animal causes the human’s skin integrity to be compromised through a bite or 
scratch. While most studies suggest that transmission to humans is rare between owners and 
pets, human to pet is not uncommon and as dogs can carry S. aureus asymptomatically, there 
is a risk that companion animals may provide an under-reported reservoir for drug resistant 
(including methicillin, tetracycline and vancomycin, some of the most widely used and 
otherwise most effective) S. aureus (Boost et al., 2008; Kottler et al., 2010; Han et al., 2016). 
Boost et al. (2008), also reported that observed strains of S. aureus were healthcare associated, 
suggesting that dogs act as a reservoir of nosocomial infections outside healthcare facilities.  
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A number of case studies have arisen where immuno-compromised patients would have 
recurring infections with the same strains of virulent Methicillin Resistant S. aureus (MRSA) 
upon completion of treatment (Manian 2003; van Duijkeren et al., 2005). Investigations had to 
be undertaken in order to locate the source of these infections as it was clear that they were 
surviving outside of patients during and after treatment. Upon investigations of the patients 
homes, it was found that the same strains of MRSA were residing in the family pet, 
asymptomatically. It was only after the pets were also treated did the reinfection of the patients 
cease. This highlights the potential pets have as a reservior for S. aureus. This is of particular 
concern due to the high rates of HIV infections in South Africa (Human Sciences Research 
Council, 2014). 
As such, it has become the interest of the University of Kwa-Zulu Natal’s Genetics research 
team to investigate the prevalence of antibiotic resistant strains of S. aureus isolated from 
companion animals, to determine if dog populations are over- looked as potential reservoirs for 
drug resistant S. aureus. This information may help identify possible sources of drug resistant 
S. aureus in dogs in the greater Durban area, expose evidence of poor antibiotic regulation in 
veterinary and human medicine and provide other information to draw up risk assessments and 
epidemiologic profiles of this pathogen as a basis of future antibiotic management and 
management for veterinary and healthcare services with regard to resistant S. aureus outbreaks.  
S. aureus is not the most prevalent Staphylococcal species which inhabits dogs. That title goes 
to S. pseudointermedius which is indistinguishable from S. aureus in culture methods and 
requires genetic testing to differentiate between the two (Hanselman et al., 2009). Since 
virulence in S. aureus is not specific to the immune systems of dogs, S. aureus is somewhat in 
a delicate state when it must be isolated from dog samples due to its disadvantage existing in a 
dog host. This also means that samples are under a lot of competitive stress when they areit is 
cultured. Currently, most prevalence studies for sampling S. aureus in dogs (Boost et al., 2008; 
Kottler et al., 2010; Han et al., 2016) use Mannitol Salt Agar (MSA) as a standard for selecting 
against competing microbes for S. aureus, even though it is not recommended for 
environmental samples and can accommodate growth of many halotolerant microbes (not only 
bacteria) (Gostinčar et al., 2009). This competition and poor selective power has the potential 
for S. aureus present to be masked and considered absent, thus further under-representing the 
potential dogs could play as a reservoir for S. aureus. Thus, it would be wise to assess the rate 
of incorrect S. aureus detection due to the MSA’s ability to select against competing microbes 
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in comparison to a medium more suited to environmental samples such as HiCromeTM Aureus 
Agar Base (AAB) (HiMedia, 2015).  
 
1.2. Hypothesis 
The first hypothesis is that virulence genes and antibiotic resistance genes detected in S. aureus 
would indicate the pathogenic status of S. aureus carried by dogs in the greater Durban Area. 
The second hypothesis is that there is no significant difference in performance of MSA and 
AAB in its ability to accurately detect S. aureus from the nares of dogs. The final hypothesis 
is that these two investigations will detect no underestimation of risk associated with dogs as 
reservoir populations for S. aureus. pathogenic 
 
1.3.  Aims and Objectives: 
1.3.1. To enrich and select for S. aureus from samples using peptone water and HiCromeTM 
Aureus Agar Base and/or Mannitol Salt Agar, respectively.  
1.3.2. To isolate DNA from presumptive colonies using a simplified organic extraction 
method.  
1.3.3. To confirm species by detecting the nuc gene using conventional PCR.  
1.3.4. To establish resistance profiles of positive isolates using the Kerby-Bauer Disc 
Diffusion method and using PCR to detect common genes that cause such antibiotic 
resistance.  
1.3.5. To detect virulence genes using PCR so to draw pathological information of S. 
aureus in dogs of the greater Durban Area.  
1.3.6. To statistically interpret comparative selection data to gauge the sensitivity, selective 
power and accuracy of S. aureus selective media.  
1.3.7. To interpret the prevalence rates detected and the selection outcomes as a reflection 
of the potentialrisk dogs havepose as a reservoir population for S. aureus. 
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CHAPTER 2: LITERATURE REVIEW 
 
This literature review aims to scour previous research for knowledge that is relevant to S. 
aureus infection, transmission and drug resistance, with particular respect to human and 
companion animal interactions. It also includes the various methodologies available for 
isolation and selection of this organism. Gaps in knowledge in all these areas are explored as 
well as the detailed genetic and biochemical mechanisms that allow for S. aureus its range of 
pathogenicity.  
 
2.1. Infection 
2.1.1. Pyogenic diseases 
Humans carry many different types of bacteria on their skin, some occur naturally as part of a 
healthy microbial ecosystem and some occur as a result of contact with the surrounding 
environment. S. aureus is an opportunistic bacterium that occurs abundantly in the environment 
and occasionally in human skin and other system flora but are often associated with pus-
forming (pyogenic) diseases (Österlund et al., 1997; Jarraud et al., 2002). The most common 
pyogenic disease caused by this bacterium is Impetigo, a skin infection in the form of skin 
lesions and sores which may produce pus which is highly contagious through direct contact, 
especially when skin integrity is compromised as a result of scratching (Kumar et al., 2007). 
Other conditions associated with pyogenic staphylococcal infections include boils, pimples and 
abcesses. Burn victims and post-operative patients are also at great risk of contracting severe 
S. aureus infections in their wounds (Howden et al., 2004). 
 
2.1.2. Mange in companion animals 
Mange affects most mammals with fur and is characterised as an uncontrolled increase of 
parasitic mites that populate the animal’s skin. Mange appears as severe itching and 
inflammation of the skin, eventually resulting in hair loss, lesions and nasty scabs that can exist 
locally and globally on the animal’s body (Fourie et al., 2007). There are two types of mites 
that can cause mange like symptoms in an animal: those that burrow into the skin and those 
that remain on the skin surface causing skin irritation. Of the burrowing category, there are two 
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species, namely, Sarcoptes scabei and Notoedres cati which cause sarcoptic and notoedric 
mange, respectively. Both species have females that burrow into the skin to lay eggs which 
hatch a few days later. S. scabei infects most domestic animals except cats, while N. cati is the 
most frequently identified mite on cats, although both can infect humans for short periods of 
time (a condition commonly referred to as scabies), (Stone et al., 1972; Chakrabarti, 1986). In 
the non-burrowing category, there are three species of mite that can cause mange symptoms 
but are not transmissible to humans. Demodex canis causes demodectic mange and is most 
found on most domestic animals but is rare in cats and horses. This mite situates itself in the 
pilosebaceous glands of hair follicles causing skin irritation (Nutting, 1976). Otodectic cyanotis 
causes otodectic mange and infects the ear canals of cats and dogs (Sweatman, 1958a). 
Psoroptes cuniculi causes psoroptic mange which is most commonly found on the ears of 
rabbits. These mites feed on the animal’s skin causing the irritation (Sweatman, 1985b). All 5 
of these skin conditions will result in secondary infections caused, predominantly, by pyogenic 
opportunistic pathogens like S. aureus and S. pyogenes (Paradis, 1999). 
 
2.1.3. Attachment and basic immune system evasion 
S. aureus typically will start its infection by attaching to epithelial cells, usually in the nasal 
cavities, on the mucosal membranes. This is allowed for by surface proteins (figure 2.1) that 
can recognise fibronectin (glycoprotein that aids cell adhesion in the extracelluar matrix 
between cells), fibrinogen (a fibrin producing protein found in the plasma of blood) and 
collagen (primary protein for structural stability in conective tissue) (Ryan & Ray, 2004). S. 
aurues can then survive both among and within host cells (Liu G. , 2009) (Liu G., 2009). Once 
exposed to host tissues, S. aureus virulence genes are upregulated, allowing for infection to 
establish (Novick, Autoinduction and signal transduction in the regulation of staphylococcal 
virulence, 2003). Among these virulence genes are those that allow the cells to generate a 
capsule that has, specifically, protein A (Foster, 2005). This protein binds to the Fc subgroup 
on IgG (immunoglobulin G, a protein active in humoural immunity) preventing it from marking 
the S. aureus for opsonization (destruction via phagocytosis) (Rooijakkers et al., 2005a). S. 
aureus can also produce a coagulase enzyme that can prevent phagocytes from reaching the 
site of infection effectively (Ryan & Ray, 2004). It has also been theorised that enterotoxins 
(toxins released in the intestines), toxic shock syndrom toxins and extracellular adhesion 
proteins, all produced by S. aureus, can interrupt the T-cell receptor activation pathway, 
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preventing long term molecular memory of S. aureus infections. This is considered the most 
probable reason that S. aureus infections can recur and persist in individuals without any wane 
in severity of infection (Llewelyn & Cohen, 2002; Liu G. , 2009).  
 
Figure 2.1: Showing the surface proteins of S. aureus used for recognising attachment surfaces 
in host cells. 
 
2.2. Virulence of S. aureus 
As S. aureus is generally considered commensal when inhabiting an animal host but it is not 
unknown that it has the capacity to become virulent and cause a range of diseases under the 
right circumstances (presence of appropriate surface proteins for the given host tissue, lowered 
host immunity due to other diseases such as mange in animals or HIV in humans). These 
infections generally involve the skin and and soft tissue which can evolve into scepticemia and 
blood poisoning when toxins produced by the bacteria enter the bloodstream. This is 
particularly dangerous as it puts patients and high risk (~12% of cases in children) of infective 
endocarditis, which is associated with a high mortality rate (Corey, 2005) (Valente et al., 2005). 
Virulence in S. aureus is generally attributable to specific molecules (virulence factors), some 
coded for by specific genetic factors, that increase the potential of the bacteria to cause disease 
within the host organism. In general, these factors can be classified into 2 major groups (figure 
11 
 
2.2): those factors involved with the cell surface, i.e. factors that affect host cell attachment and 
host immune evasion (e.g. capsules), and those that are secreted by the cell. The secreted factors 
can be further split into groups including superantigens (enterotoxins), cytolytic toxins (those 
that cause tareget cell leakage or lysis, depending on concentration secreted), exoenymes that 
target specific host molecules for breakdown (e.g. lipases, proteases, etc.), and miscellaneous 
proteins (other proteins that impact the host’s immune system/immune response) (Lin & 
Peterson, 2010; Costa et al., 2013). Antibiotic resistance is considered a form of virulence, 
however, unless a strain posseses virulence factors of the above mentioned types, the antibiotic 
resistance will not affect the severity of infection of the bacteria. That being said, virulent 
strains which acquire antibiotic resistance prove to be some of the most troublesome pathogens 
encountered by modern medicine (such as MRSA).  
 
Figure 2.2: General classifications of Virulence factors found in S. aureus 
As it has been known for the last two decades, S. aureus is most famous for its huge variety of 
different virulence factors, with different mechanisms and functions and so discussing each 
factor, its metabolic pathways, mechanisms and genetic elements in great detail would be more 
appropriately done so in a textbook or a series of reviews. So discussed below, in a more 
general fashion, are some of the more prevalent virulence factors expressed by S. aureus, their 
genetic elements and means of acquisition of such virulence factors. 
 
2.2.1. Cell surface factors 
Cell surface virulence factors are those that directly involve the interaction between bacterium 
cell surface and host molecules or surfaces. There are three main groups of cell surface factors,  
Microbial Surface Components Recognising Adhesive Matrix Molecules (MSCRAMM’s), 
Virulence
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Secreted 
factors
Enterotoxins
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capsule polysaccharides and staphyloxanthin. All these factors are expressed or produced 
during the initial and log phases of growth in order to establish residence within host tissues.  
 
2.2.1.1. MSCRAMM’s 
MSCRAMM’s are directly involved with the first steps of infection via the attachment to host 
tissues (figure 2.1). The two most prevalent of these, are staphylococcal protein A (SpA) and 
fibronectin-binding protein A (FnbpA or FnbA). (Bhatty et al., 2013; Votintseva et al., 2014).  
SpA, coded for by spa is a chromosomally located gene, and can be found in all naturally 
occuring strains (Patel et al., 1989). It has the important function of binding to the Fc site of 
immunoglobulin G (the site that triggers phagocytosis, see figure 2.3), thus hiding themselves 
from being marked for phagocytosis by host macrophages. This defense mechanism works 
incredibly well with capsule polysaccharides which can be excreted as they too make 
phagocytosis and opsonization difficult for the host and allow for colonies to persist within 
mucosal membranes of the host (nasal, oral, vaginal, intestinal).  
 
Figure 2.3: Showing the mechanism of action for immunoglobulin G for marking invading 
bodies for phagocytosis, in the absence (a) and presence (b) of staphylococcal protein A 
Despite being present in all strains, there is plenty sequence variation in the spa gene. Some 
variants were recently untypeable until a new typing method was developed in 2014 
(Votintseva et al., 2014). This study suggested that some previously untyped strains that have 
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been found commonly in livestock have most likely been underrepresented in human typing 
studies, suggesting that there may be even more sharing of S. aureus strains between animals 
and humans than previously though. However, it is not known by how much it has been 
underestimated.  This also proves that there as been a great underestimation of the diversity 
and prevalence of the carriage of mixed strains, but by how much is still unknown.  
The spa gene is an approximately 2kb gene made up of 3 distinct regions (figure 2.4), the FC 
region which codes for the subunits for IgG binding of protein A, the Xc region which codes 
for the subunits for the binding of protein A to S. aureus’s cell surface, and the Xr region which 
does not have a clear function but does generate peptides that can induce type I interferon (type 
I IFN) signaling in host cells (Martin et al., 2009; Furuya et al., 2010). As the type I INF 
pathway is primarily used for halting various stages of viral infection which inludes inhibiting 
translation mechanisms, this results in an increased virulence for infecting S. aureus cells 
(Schoggins & Rice, 2011; Markušić et al., 2014). The Xr region varies in size as it is a short 
sequence repeat region (SSR) that has 24bp repeat units that vary in sequence and number, 
combinations of which are specific to the S. aureus strain. Typing of this region involves the 
amplification of the Xr region using conventional PCR primers and then sequencing of the 
product (Shopsin et al., 1999; Harmsen et al., 2003; O’Hara et al., 2016). Sequences can then 
be compared to those in the Rindom SpaServer database (http://www.spaserver.ridom.de/) run 
by Rindom Bioinformatics and a spa-type will be assigned. The known spa-repeats can 
theoretically define as many as 17563 spa-types in varying combinations.  
 
Figure 2.4: Structure of spa gene showing FC subunits S, A-E, and Xr and Xc regions. Arrows 
indicate the region from which primers are designed for spa typing.  
Fibronectin-binding protein A (FnbA) is one of the most prevalent virulence factors found in 
S. aureus, with its gene fnbA being present in about 83 to 88% of clinical isolates while its 
relative fibronectin-bindimg protein B (FnbB) with its gene fnbB occurs at about half that 
frequency (Bhatty et al., 2013; Mirzaee et al., 2015). Other studies showed more varied 
frequencies (up to 98% for fnbA and 99% for fnbB), whose variation was simply attibuted to 
sampling biases, source of isolated samples, and the genetic background of said samples. The 
only consistant variation seen was that MRSA isolated generally had higher instance of FnbP 
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being present than in MSSA isolates (difference averageing at ~10%) and that isolates from 
healthy patients (usually nasal carriage) had much lower FnbP gene frequencies (76%) (Rice 
et al., 2001; Arciola, et al., 2012).  
The genes fnbA and fnbB are found chromosomally and are not transmitted horizontally 
between strains but rather are inherited. These proteins allow for S. aureus to bind to fibronectin 
proteins found which are important structural and antimicrobial molecules found in fibrous 
connective, blood clots at wound sites and in the saliva of vertabrate animals. In saliva, 
fibronectin can prevent the adhesion of certain bacteria to the pharynx and buccal cells (Hasty 
& Simpson, 1987; Valenick et al., 2010).  
As S. aureus  can use fibronectin binding as a means of anchorage to host tissue, this allows it 
to readily infect wounds, especially those involving skin and soft tissue. Mutant studies showed 
that when strains with non-functional FnbA proteins were introduced to blood clot assays, there 
was no initiation of infection, suggesting that this virulence factor is probably the most 
important factor for the pathogenesis of S. aureus, and even without any other virulence factors 
present, S. aureus can cause illness: even polystyrene beads coated with fibronectin binding 
protein established infection in cell cultures of human embryonic kidney cells (Sinha et al., 
2000). With such information, it is would be of great benefit to develop a drug, or even a topical 
treatment that inactivates the FnbP’s that could be applied to wounds as well as internalised 
devices such as catheters, IV drip needles, etc.  
 
2.2.1.2. Capsules 
Capsules can also be produced by S. aureus. This is the formation of a polysaccharide matrix 
that surrounds the cell, exterior to the cell wall, that has a multifaceted function. The most 
important function is that the matrix protects surface proteins from being recognised by host 
immune antibiodies and so the bacteria cannot be marked for phagocytosis (O'Riordan & Lee, 
2004). It has been understood for some time that the biosynthesis of this extracellular matrix is 
determined by a gene cluster designated as a CP (capsular polysaccharide) biosynthetic cluster, 
of which there are multiple serotypes, the most common ones being CP5 (50% of isolates) and 
CP8 (25% of isolates) which have many genes within of which 75% are almost identical, with 
cap5 and cap8 genes being allelic in the respective clusters. Despite the detailed sequence 
understanding of these clusters, it has only recently been elucidated, how the some of the 
enzymes coded for in within, participate in the biosynthesis of these polysaccharides (Li et al., 
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2014). This has opened up the opportunity to develop drugs that can target the enzymes 
involved in polysaccharide precursor synthesis so to bypass the pathogenicity of S. aureus 
enabled by the presence of a capsule.  
These gene clusters have no affiliation to plasmids and are situated chromosomally. While 
serotypes 5 and 8 are most common, they are not the most pathogenic. CP1 has proven to cause 
the most virulent infections, as it allows for greater resistance to phagocytosis and is even lethal 
to mice (Lee et al., 1987). This is due to the presence of  the gene cap1. Unlike cap5 and cap8, 
cap1 is not allelic but rather resides in its own discrete genetic element with flanking regions. 
What is so interesting about this is that this element was found to resemble that of the 
Staphylococcal Cassette Chromosome (SCC) so often associated with carrying the methicillin-
resistance determining gene, mecA (SCCmec) (Luong et al., 2002) (see part 2.4 for disccussion 
of SCCmec).  
However, the element is not mobile, thus it cannot be transmitted between strains. Flanking the 
SCCcap1 locus was the gene for a (at the time) novel enterotoxin. It was suggested that the 2 
genetic elements were inserted into genome at independent events but are carried together, 
suggesting that the lethality of CP1 was actually attributable to that toxin and not the capsule 
as previously thought. This means that if expression of that toxin can be deactivated or the 
toxicity of the molecule produced is neutralised, the pathogenicity of CP1 type strains of S. 
aureus can be greatly reduced.  
 
2.2.2. Secreted Factors 
Secreted virulence factors are proteins that are synthesised within the cell but their primary 
funtions are outside the cell, away from the cell surface, usually interacting with host 
tissues/molecules. There are four categories of secreted virulence factors including 
superantigens (also referred to as enterotoxins), cytolytic toxins, exoenzymes and 
miscellaneous proteins (Costa et al., 2013). All of these factors are expressed during the 
stationary phase of growth, after infection is established. Discussed here are those secreted 
factors that have been found on mobile genetic elements, (discussing all factors would be time 
consuming and more detailed information can be easily found in other sources).  
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2.2.2.1. Superantigens 
Superantigens include both the enterotoxins and the toxic shock syndrome toxin-1 (TSST-1). 
These superantigens are enzymes that have a poisonous affect on the host. This does not include 
enzymes involved in interactions with the host immune system directly. There are 22 
enterotoxins (A through V), including staphylococcal-like enterotoxins (SEl’s) all of which are 
coded for by mobile genetic elements. Most famously, these enterotoxins (SE’s) are known to 
cause food poisoning that involves a range of symptoms, sometimes including severe 
dehydration due to excessive vomiting and diarrhea, commonly reffered to as Staphylococcal 
Food Poisoning (SFP). This is generally self-limiting as the infection will clear within a few 
days once the body has flushed it out, and so hospitilisation is rarely neccesary except for cases 
with extreme dehydration (Argudín et al., 2010). Even when S. aureus is destroyed by the gut 
or by high temperatures caused by a fever, the toxins will remain intact and are even resistant 
to proteolytic enzymes, causing damage to the host until completely passed throught the 
gastrointestinal tract (Larkin et al., 2009). The two major groups of staphylococcal 
superantigens (SE’s and SEl’s) are grouped according to their ability to cause an emetic 
resposnse in a primate model (SE’s) or the lack there of (SEl’s). The SE’s are most famous for 
the five classic toxins SEA to SEE, most highly associated with SFP. However, according to 
amino acid sequence, these enterotoxins can be grouped into four or five groups (table 2.1) 
(four if SEH is put with group one or five if SEH is grouped seperately, depending on the 
author) (Proft & Fraser, 2003; Thomas et al., 2007).  
Table 2.1: Grouping of staphylococcal and staphylococcal-like enterotoxins according to 
amino acid sequence. Note: depending on the author SEH can fall into group 1 or its own group.  
Group Superantigen 
1 SEA, SED, SEE, SEH*, SElJ, SElN, SElO, SElP, SES 
2 SEB, SEC, SEG, SER, SElU, SElU2 
3 SEI, SElK, SElL, SElM, SElQ, SElV 
4 SET 
5 SEH* 
 
Superantigens work by interacting with class II MHC and with T-cells. Under normal 
circumstances antigen-presenting cells (APC’s) will engulf and breakdown microbial antigens, 
only to use them as small peptides bound to class II MHC molecules on its cell surface. This 
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invites T-cells to recognise this complex with their T-cell receptors (TcR’s) in order to trigger 
an immune response against that specific antigen (0.01 to 0.001% of T-cells are activated) 
(Lanzavecchia, 1985; Holling et al., 2004). Superantigens will complete this process while 
bypassing the antigen recognition step by directly crosslinking the class II MHC of the APC to 
the TcR’s on T-cells. Because this is non-specific antigen-mediated binding, up to 30% of T-
cells can be activated at once, causing a severly over-exaggerated immune response, causing 
shock (Fraser, 2011) (figure 2.5). 
 
Figure 2.5: Showing the response to foreign antigens under normal circumstances and in the 
presence of a super antigen 
It must be clearly differentiated that this is superantigenic activity which can only occur when 
superantigens enter the blood stream and can be potentially life threatening. This is not the 
activity observed when enterotoxins remain in the GI tract. The mechanism as to how these 
toxins cause GI distress is not well understood but is but is most likely involved with the 
activation of cytokine release, causing damage to the surrounding tissue due to cell apoptosis 
(Lin et al., 2011; Otto, 2014). Table 2.1 shows that there is no obvious correlation between the 
related sequence group and whether the superantigen has an emetic effect. Much research has 
gone into trying to find the sequence related origin of what causes emesis with these 
superantigens, but with no luck, no difinitive evidence has arisen (Proft & Fraser, 2003). 
However, if the mechanisms by which enterotoxins maintain their toxicity within the GI tract, 
it may shed light onto how the sequences contribute to that, which in turn could highlight the 
sequence responsible for emetic reactions to particular SE’s.  
2.2.2.1.1. Mobile Genetic Elements of Superantigens 
Genes which code for SE’s and SEl’s have been found carried by a plethora of various mobile 
genetic elements including plasmids, prophages, pathogenicity islands (SaPI’s) and genomic 
islands.  
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Genomic Islands 
Unlike the other elements, genomic islands make up part of the genome and so far no evidence 
has been found that they may move out of the genome for purposes of horizontal gene transfer. 
Two major pathogenicity islands found exclusively in S. aureus are vSaα and vSaβ both of 
which will occasionally carry an enterotoxin gene cluster (egc). This cluster has four main 
variants which include the genes seg, sei, selm, and selo, among others including seln, selv and 
selu which differ per variant (Collery et al., 2009). It has been hypothesised that these egc’s 
were originally from on SE gene that through its own duplication and then subsequent 
variation, gave rise to the se genes currently observed in egc’s (Jarraud et al., 2001). One of 
the most curious things about these gene clusters is that they can be found within commensal 
type strains of S. aureus without any sepsis occuring in the host.  
Unlike other toxins (with special mention of SEA, coded for by sea), which can cause severe 
symptoms in the host, these egc genes refrain from causing major damage to the host. van 
Belkum et al. (2006), concluded that this must be as a result of one of the egc genes providing 
the host with some protection against sepsis (this is beneficial for the bacteria as sepsis is self 
limiting whereas commensalism is preferable for long-term survival of the bacteria). However, 
this theory is yet to be investigated. They also found that in invasive isolates of S. aureus, there 
was a slightly lower prevalence (54% versus 63%) of the egc elements than in isolates from 
healthy carriers (P = 0.03) (van Belkum et al., 2006).  
 
Staphylococcal Pathogenicity Islands (SaPI’s) 
SaPI’s, the most common of se and sel associated mobile genetic elements, are able to move 
in and out of the genome at specific sites, in a specific orientation. There are many SaPI’s, all 
with similar in structures, with the same insertion site and orientation with the S. aureus 
genome (Argudín et al., 2010). Their structure is also quite conserved when compared to most 
temperate bacteriophages, in fact SaPI’s even require particular certain helper phages to induce 
their replication outside of the S. aureus genome, in order for copies to be transmitted between 
bacteria horizontally. The great number of pathogenicity island variants (as of 2010, at least 20 
have been fully sequenced) even allow for some to be transmittable between different 
Staphylococcus species (Tallent et al., 2007). These pathogenicity islands usually carry the 
19 
 
toxic shock syndrome toxin (TSST-1) gene, tst along with two to three other se’s/sel’s (Dinges 
et al, 2000; Novick & Subedi, 2007).  
TSST-1 differs from the enterotoxins in that it can cross mucosal surfaces and does not 
specifically have to be ingested or absorbed through the GI tract. This is why so many cases of 
toxic shock syndrome (TSS) are mentrual related (around 90% of TSS cases are menstrual 
related (Lin & Peterson, 2010)). However, not all TSST-1 induced cases of TSS are menstural. 
Some cases are as a result of post-surgery complications, burns or pneumonia, particularly at 
sites where there is a mucosal surface to travel across. About half of cases of non-menstrual 
TSS have been reported with enterotoxins SEB and SEC being the primary cause and not 
TSST-1. According to Foster  (2005) 25% of clinical S. aureus isolates carry the tst gene. 
However, it has been noted that not all of the alleles are functional. One allele which allows 
for the substitution of H135A which results in a structurally decent yet functionally inactive 
version of the TSST-1 protein (a toxoid protein). In a study by Spaulding et al, (2012), this 
version was used as a vaccination in rabbits to successfully prevent superantigenic reactions 
from the functional versions of TSST-1 that cause serious illness. This is an important step for 
developing better combative mechanisms against superantigenic activity of S. aureus and 
further toxoid substances should be developed or sought out for toxins produced by other 
bacteria as well as S. aureus. 
 
Plasmids 
Plasmids are some of the most well understood mobile genetic elements and are especially 
important in that they possess the unique ability to perform conjugation, an elegant manner of 
horizontal gene transfer. S. aureus too utilises plasmids for harbouring se and sel genes. Two 
types of plasmids that carry enterotoxins have been characterised, pIB485 and pF5 (including 
pF5-like) which carry ser and selj genes. pIB485 also carries sed and pF5 will occasionally 
also carry ses and set (Omoe et al., 2003). The gene for SEB, seb has also been observed within 
a plasmid, pZA10, along with sec1, both of which are more often seen carried by 
staphylococcal pathogenicity islands (SaPI’s) than pZA10 (Hu & Nakane, 2014).  
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Prophages 
Prophages are bacteriophages that integrate their genetic material into the host’s genome. 
Prophages that are specific to infecting S. aureus with additional se and sel genes most often 
belong to the Siphoviridae family. These phages will infect S. aureus with the usual 
mechanisms of bacteriophage infection but the conversion into a prophage is achieved through 
a recombination event, directed by an integrase (coded for by int on the phage genetic material) 
that inserts the attP site of the phage DNA into the attB site in S. aureus’s genome (Deghorain 
& Van Melderen, 2012). The attB site in the S. aureus genome actually falls within the β-
haemolysin gene (hlb), another virulence gene. As expected, this does inactivate this naturally 
occuring virulence gene but this loss is recompensed by the acquisition of new virulence genes, 
sometimes more than just one including sea, selk, selq and selp.  
The most toxic of the enterotoxins and the most highly associated with cases food of food 
poisoning is SEA coded for by sea. Some sea only phages have been found in troublesome 
strains of MRSA and VRSA (Argudín et al., 2010). It has also been found that most strains of 
MRSA are toxin carrying strains (Schmitz et al., 1997). SEE, coded for by see is also a phage-
mediated enterotoxin gene and also the second most prevalent enterotoxin associated with SFP 
(Mashouf et al., 2015). To date there are at least 8 characterised phages that carry sea, and what 
with the ubiquitous nature of bacteriophages, there are any number of bacteriophages that could 
potentially carry SE’s (Schelin et al., 2011). Naturally, these prophages all have the ability to 
revert to the lytic cycle if conditions become unfavourable, in order to release progeny 
prophages, which can then infect other S. aureus strains, thus proving their threat through both 
vertical and horizontal gene transfer.  
 
2.2.2.1.2. The Immune Evasion Cluster (IEC) 
Apart from enterotoxin genes, many of these prophages have been found carrying other 
virulence genes such as chp, scn and sak genes which are closely situated on the phage genome, 
making up part of the innate immune evasion cluster (van Wamel et al., 2006). The Immune 
Evasion Cluster (IEC)  is a gene cassette carried most often by β-haemolysin converting 
bacterophages (βC-ϕ’s) and carries a number of immune modifying enzyme genes that enable 
the infecting bacterium to better bypass the host’s innate immune system. The genes most often 
carried within this cluster include chemotaxis inhibitory protein of S. aureus (CHIPS coded for 
by chp), staphylococcal compliment inhibitor (SCIN coded for by scn), staphylokinase (SAK 
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coded for by sak), enterotoxin A (sea) or enterotoxin-like P (sep). All seven of the characterised 
variants of IEC carry the gene for scn and some combination of the other three genes (Verkaika 
et al., 2011; van Wamel et al., 2006)(see figure 2.6). 
The vehicle for IEC’s are aptly named βC-ϕ’s as the attachment site for the prophage is found 
within the β-haemolysin gene, hbl. As mentioned before, this will result in the inactivation of 
hbl but this form of virulence is recompensed by the addition of multiple new genes that allow 
for better protection against the host’s innate immune system. All genes products included in 
the IEC (with the exception of sea) show strict specificity to the human immune system and 
would otherwise not affect dogs, however, if isolates are carrying genes from the IEC, if 
transmitted to humans, would still be effective against human hosts (Rooijakkers et al., 2006).  
 
Figure 2.6: Variations of Immune Evasion Clusters that can be found in β-haemolysin 
converting prophages (van Wamel et al., 2006) 
 
Chemotaxis Inhibitory Proteins (CHIPS) 
Anaphylatoxins are specialised proteins produced as part of the human immune compliment 
system. These proteins (namely C3a, C4a and C5a) are part of a biochemical process that 
causes an inflammatory response to an antigen, in context of this study, an S. aureus infection 
(Fritzinger et al., 1992). Another type of protein that also allows for chemotaxis as well as the 
activation of phagocytes is the chemotactic factor, also referred to as fMLP (N-
Formylmethionyl-leucyl-phenylalanine) (Panaro & Mitolo, 1999). These proteins specifically 
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allow for chemotaxis, which is the process whereby neutrophils and monocytes (phagocytic 
white blood cells) move out of the blood stream (diapedesis) and toward the site of infection 
by following an increasing concentration of these anaphylatoxins. Once at the site of infection 
the neutrophils and monocytes will attempt to destroy invading pathogens via phagocytosis 
(Rooijakkers et al., 2006; Postma et al., 2004). CHIPs (chemotaxis inhibitory proteins) coded 
for by chp, bind to C5a and fMLP proteins, thus preventing chemotaxis and stalling the early 
detection systems of the host immune system. While chp on its own does not allow for more 
serious morbidity, in conjunction with other virulence factors, with specific reference to the 
enterotoxins, the presence of chp can allow for a longer window of opportunity to cause as 
much toxicity as possible before the host’s immue system can successfully target the invading 
pathogen. This is especially effective as chp is expressed during the exponential phase of 
growth (Rooijakkers et al., 2006).  
 
Staphylococcal Compliment Inhibitor (SCN) 
Also expressed during exponential growth is scn which codes for the protein SCIN, 
Staphylococcal complement inhibitor. According to the conditions used in the study by 
Rooijakkers et al., (2006), the promotor region for this gene is five times more active than the 
other genes making up the IEC. SCIN, like CHIPS, prevents opsonisation and phagocytosis by 
interacting with the compliment pathway. Unlike CHIPS, SCIN binds specifically with C3 
convertases that are already attached to the microbe, thus preventing the formation of 
downstream molecules that allow for phagocytosis and opsonisation (Rooijakkers et al., 2005; 
Rooijakkers et al., 2007). Naturally, it would be more economical that scn is expressed more 
than chp as it targets molecules upstream of those targeted by chp, however, this does not 
necessarily apply to conditions not specified by that study (Rooijakkers et al., 2006), and more 
research should be conducted in vivo to determine if this is the case in actual infection 
conditions.  
 
Staphylokinase (SAK) 
Staphylokinase or SAK, expressed product of sak, is produced during the late exponential 
phase an and employs two immune evasion tactics. It is able to bind to both plasminogins and 
α-defensins. S. aureus is able to capture host plasminogens (the inactive precursors to plasmin) 
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on its cell surface it can allow for SAK-mediated activation of the plasminogen into plasmin 
(Molkanen et al., 2002). Once activacted, plasmin, a broad spectrum proteolytic enzyme which 
is able to break down the fibrin network formed to clot blood (Law et al., 2012). This 
prevention of blood clotting may help prevent lacolising the site of infection. SAK also binds 
with defensins.  
Defensins are host produced proteins that are rich with positively charged amino acid 
functional groups. This draws the defensins to the negatively charged phospholipids of the 
bacterial cell membrane. Defensins are also folded in a polar manor such that opposite to the 
positive end are hydrophobic amino acid groups. Once in contact with the bacterial cell wall, 
the hydrophobic end of the defensin will bury itself into the cell membrane with phospholipid 
heads clustered all the way around the molecule, forming a hole in the cell membrane (Hazlett 
& Wu, 2010). Naturally, enough holes will cause the invading pathogen to lose osmotic 
pressure and die. SAK can bind to and inactivate these defensins preventing this from occuring 
(Bokarewa et al., 2006) . However, the role SAK plays in the infection processes is not fully 
understood as Jin et al. (2003) observed that patients with S. aureus isolates that did not carry 
the sak gene were 3 to 4 times more likely to be lethal than those isolates that did carry it 
(Kwieciński et al., 2010) and it has also been noted that the sak gene is expressed far more in 
mucosal and skin isolates than isolates invading internal organs.  
 
2.3. Transmission 
While S. aureus is opportunistic and is transferred between humans primarily through contact 
(Koenig et al., 2016) (Jacobs, 2014), and is commonly understood to be a zoonotic microbe 
(Public Health Agency of Canada, 2011), there is some uncertainty about the rates of transfer 
from dogs to humans and humans to dogs. A cross-sectional study done by Boost et al., (2008) 
showed that of 17 owners and their dogs (not limited to one dog per owner) that tested positive 
for S. aureus, 6 sets had isolates with indistinguishable Pulse Field Gel Eelectrophoresis 
(PFGE) profile. This suggested that there was transfer between owner and dog. However, 
according to the questionaires completed by the owners, transfer was less associated with the 
manner of contact with the pets (petting, licking the owner’s face etc.) but rather with the 
profession of the owner. More specifically, healthcare workers showed the highest association 
with identical PFGE profiles between owner and dog than any other profession. This suggests 
that transfer from owner-to-dog is more likely than dog-to-owner. The authors did however 
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suggest that a larger sample size with bigger control groups should be conducted to prove or 
disprove that hypothesis.  
Earlier studies have confirmed that MRSA carriage in companion animals can still pose a threat 
to their human owners. A surveillance study by Middleton et al. (2005) at Veterinary teaching 
hospitals across the United States showed that 65 animals (mostly dogs and horses but also 
including birds, cats and cattle) carried 70 isolates of S. aureus, 58 with unique typing profiles 
and all MRSA strains (14% of animals carried MRSA) were distinguishable by PFGE. What 
is interesting to note is that, Middleton et al. (2005) reported that the infections appeared to be 
community-acquired as opposed to hospital-acquired, and that acquisition from the community 
occurs at rates similar to hospital-acquired S. aureus infections (Duquette & Nuttal, 2004). 
There is currently no data for South African domestic animals as focus has mainly been on 
livestock (Schaumburg et al., 2014). While it is understood that transfer to healthy humans is 
rare, there is still great risk for those individuals who are immunocopmromised.  
A case study showed the chronic MRSA reinfenction of the leg stump of man with diabetes 
mellitis and his wife, a transplant patient also with diabetes, symptomatic of cellulitis (Manian, 
2003). They jointly owned an asymptomatic dog that shared very close contact with them, such 
as kisses, licking of faces and sleeping on the bed with its owners. It was found that the dog 
carried a strain of MRSA indistinguishable by PFGE to that which kept recolonising the two 
patients. Only after decolonisation of the MRSA from the dog and the limited intimate contact 
with the dog were decolonising therapies of the couple successful. The dog was healthy and 
had no prior exposure to antibiotics and so it is assumed that its MRSA was originally acquired 
from its owners, who most probably acquired it nosocomially. In turn, the dog acted as a 
reservior of MRSA which constantly reinfected its owners.  
Another study observed a woman admitted to hospital for diabetic foot that had ulcerated with 
positive cultures for fusidic acid and tetracycline resistant MRSA (van Duijkeren et al., 2005). 
The patient was successfully treated for the infection but it recurred as a urinary tract infection 
months later with resistance patterns identical to the previously isolated strain. After the second 
round of treatment, the patient followed a 6 month screening regime to monitor if she would 
reacquire that strain of MRSA as a carrier. On the final screening she was tested positive for 
the same strain of MRSA. Subsequent screening of her husband, son and dog showed they too 
were carriers of the same strain (indistinguishable by PFGE). All were treated with successful 
eradication of that MRSA strain for at least the 6 month screening process subsequent to 
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antibiotic treatment. It was assumed that the woman initially transmitted the MRSA to the other 
members of her household who subsequently reinfected her, although there was no medical 
history given for the dog. Without that information, it cannot be determined whether the dog 
acquired it communally or through its own exposure to antibiotics.  
 
2.4. Antibiotic Resistance 
Penicillin was the greatest combatant against S. aureus in the early to mid-20th century and by 
the 40’s, penicillin resistant strains arose, which led to the increased use of methicillin as an 
alternative to penicillin, in turn selecting for methicillin-resistant strains which arose in the 
early 60’s: the infamous MRSA (methicillin resistant S. aureus) (Lowy, 2003). This strain had 
developed a broad resistance to penicillin-derived antibiotics known as β-lactams including 
oxacillin and cefoxitin (Fernandes et al., 2005). It did so due to an acquired plasmid carrying 
the code for an enzyme called penicillin binding protein 2a (PBP2a) that can hydrolyse the β-
lactam ring which confers antibiotic capabilities to β-lactam antibiotics like penicillin and its 
derivatives (Chambers & DeLeo, 2009). In 2010, a meta-analysis was carried out by Logman 
et al., to investigate which non-β-lactam antibiotics are effective against MRSA and it was 
found that linezolid and some glycopeptide antibiotics were effective against skin and soft 
tissue infections of MRSA (Logman et al., 2010). However there have been increasing 
incidents of resistance to most types of antibiotics, not only the above mentioned, worldwide, 
making the need to study and understand the mechanisms of resistance and resistance 
conference all the more important.  
According to the data collated by the European Committee on Antimicrobial Susceptibility 
Testing (EUCAST), the following antibiotics in Table 2.2 (from different antibiotic classes) 
are the more prevalent antibiotics used against S. aureus all of which have documented cases 
of resistance (EUCAST, 2016). There are other antibiotics that have prevalent use agains S. 
aureus but have been ommited as more prevalent representatives of that class have been 
included below.  
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Table 2.2: Names and classes of antibiotics discussed in this review. 
Antibiotic Name Antibiotic Class 
Cefoxitin (methicillin alternative) Cephamycin  
Ceftoroline Cephalosporin 
Ciprofloxacin Fluoroquinolone 
Clindamycin Lincosamide 
Erythromycin Macrolide 
Gentamycin Aminoglycoside 
Linezolid Oxazolidinone 
Teicoplanin Glycopeptide 
Tetracycline Tetracycline 
Vancomycin Glycopeptide 
 
2.4.1. Cefoxitin 
Cefoxitin is a 2nd-generation cephamycin (often grouped with cephalosporins), a sub-class of 
antibiotics grouped with penicillins to form the class of β-lactams, as both groups contain β-
lactam rings. It is used against a broad spectrum of both Gram-positive and Gram-negative 
bacterial infections (Onishi et al., 1974; Guignard et al., 2004). Cefoxitin was originally used 
against extended spectrum β-lactamase producing organsims such as MRSA (Jarlier et al., 
1988; Fuda et al., 2005). It works in a very similar way to penicillin in that it binds to the 
reaction site of transpeptidase enzymes originally purposed for catalysing crosslinkage 
between peptidoglycan chains, thus reinforcing the structure of the cell wall (Stapleton & 
Taylor, 2002) (figure 2.7). These enzymes are also reffered to as penicillin binding proteins 
(PBPs). Before the development of 2nd generation penicillins (methicillin and oxacillin) and 
cephamycins (cefoxitin), penicillins could be broken down if the target cells carried β-
lactamase which could hydrolyse the β-lactam ring in penicillins and cephalosporins before 
they took effect. These 2nd generation β-lactams were designed to have functional groups that 
sterically hinder the enzymes from recognising them as substrates (Chambers, 1997). However, 
resistance to these too emerged in the form of a modified transpeptidase enzyme that could 
carry out its function as a transpeptidase but will not bind to these 2nd generation β-lactams 
(figure 2.7).  
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Figure 2.7: The mechanism of action of β-lactam antibiotics and the mechanism of resistance 
to β-lactam antibiotics with modified transpeptidase enzyme. 
Strains resistant to 2nd generation β-lactams have PBP2a which is coded for by the mec gene 
set which includes mecA which codes for the PBP2a protein and mecR1 and mecI which code 
for transcription regulation elements. It is suggested that the most probable source of mec was 
through the acquisition of some cromosomal DNA via mobile genetic elements from 
Staphylococcus fleurettii (Tsubakishita et al., 2010). Research by Tsubakishita et al. (2010) 
also suggests that this segment of DNA with mec is most likely what evolved to be the 
Staphylococcal Cassette Chromosome (SCCmec) which is so broadly studied today.  
Staphyococcal Cassette Chromosome (SCCmec) can be found integrated with S. aureus’s 
chromosome or may remain as a mobile genetic element. Within it are four definitve elements 
(Figure 2.8), two of which are also used to classify variants of SCCmec into allotypes, the mec 
region and ccr region (table 2.3). The mec element is composed of the mec gene set (mecA, 
mecR1 and mecI) coding for resistance to methicillin and some other β-lactams. The ccr 
element is composed of the ccr gene set and open reading frames (ORF’s) surrounding the ccr 
gene set (Chongtrakool et al., 2006).  
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Figure 2.8: Showing anatomy and homology of the SCCmec types  
The ccr gene set carries the sequences of unique site specific cassette chromosome 
recombinases which direct site and orientation specific excision and integration of SCCmec in 
and out of the host’s chromosome. The surrounding ORFs are of unknown function. There are 
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three main ccr types (A, B and C), each with less than 50% sequence identity. Types A and B 
each have four (A1-4 and B1-4) subtypes and will often occur together (see table 2.3). The 
other two elements are the insertion site sequence (ISS), found upstream or downstream of the 
mec complex, and the direct repeats which flank the ISS. The ISS is the target of the ccr 
recombinases, allowing the integration of the SCCmec at a specific site in the staphylococcal 
chromosome. The different insertion sequences that associate with the mecA gene are what is 
used to distinguish the classes of the mec complex. (IWG-SCC, 2009). A fifth element, not 
essential to the functioning of the cassette are the J-regions. They are regions of DNA that 
“join” the mec and ccr regions (between and on either side). These regions are acknowledged 
as they may carry resistance genes to other antibiotics (Valsesia et al., 2010).  
Table 2.3: Showing mec complex classes and ccr complex types that define the 8 major 
allotypes of the SCCmec 
SCCmec Type mec complex Class ccr complex Type (included subtypes) 
I B 1 (A1B1) 
II A 2 (A2B2) 
III A 3 (A3B3) 
IV B 2 (A2B2) 
V C2 5 (C) 
VI B 4 (A4B4) 
VII C1 5 (C) 
VIII A 4 (A4B4) 
 
2.4.2. Ceftaroline 
Ceftaroline is a 5th-generation cephalosporin antibiotic used to treat skin and soft tissue 
infections and has proven effective against a broad spectrum of Gram-positive bacteria 
including MRSA and multidrug resistant MRSA, including vancomycin resistant strains 
(Kollef, 2009) (Duplessis & Crum-Cianflone, 2011). It is administered as a prodrug in acetate 
form (ceftaroline fosamil) which breaks down into the active ceftaroline drug and the inactive 
ceftaroline-M1 metabolite (Yukihiro & Junko, 2008). It is made up of a β-lactam ring and a 
cepham ring like most cephalosporins but its most usful structure is a thiazole ring which has 
high binding affinities with PBP2a expressed by MRSA, rendering the bacteria susceptable to 
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the β-lactam and cepham ring structures of a second ceftaroline molecule which block the 
active site of PBP2a from carrying out its function as a crosslinking enzyme in the 
peptidoglycan layer of the cell wall (Ishikawa & Nobuyuki, 2003; Harrison et al., 2015). In a 
recent study by Long et al., (2014), ceftaroline-resistant strains of MRSA were isolated from 
the blood of a cystic fibrosis patient in addition to the 5 other strains of MRSA isolated from 
the patient’s airway. This resistance was not community acquired as it was a direct result of 
antibiotic exposure. It was found that the resistance to ceftaroline was confered by 2 non-
synonymous SNP mutations in the mecA gene (which codes for PBP2a), causing amino acid 
changes Y446N and E447K that prevented ceftaroline from binding to and inactivating the 
PBP2a protein (Long et al., 2014). These mutations have also been related to resistance of 
MRSA against cetobiprole, another cephalosporins closly related to ceftaroline (Banerjee et 
al., 2008).  
 
2.4.3. Ciprofloxacin 
Ciprofloxacin is a 2nd-generation fluoroquinolone that is used to treat internal infections 
(gastrointestinal, respiratory, urinary-tract, joint) as well as some skin infections, and can be 
used against a broad spectrum of bacteria, including both Gram-negative and Gram-positive 
bacteria (Committee on Antimicrobial Agents, 1994). It works by inhibiting the functions of 
DNA gyrase and topoisomerase IV, both are type 2 topoisomerases, which control the 
seperation of DNA strands for replication, thus preventing effective cell replication (Drlica & 
Zhao, 1997) (Piercy et al., 1989). It does this by ciprofloxacin binding to subunits GyrA and 
GyrB of DNA gyrase or to the respectively homologous subunits of topoisomerase IV, ParC 
and ParE. As these enzymes form a complex with DNA during replication in order to unwind 
it trough use of double stranded breaks, when the fluoroquinolone binds to it, the double 
stranded break cannot successfully be resealed (Hooper, 2001).  
Resistance to ciprofloxacin treatment by clinical S. aureus samples was first published in 1986 
and by 1994 it had been established that resistance was due to SNPs in grlA and glrB in 
topoisomerase IV, which code for subunits ParC and ParE, respectively (ciprofloxacin’s 
primary target in S. aureus) and in SNPs in gyrA and gyrB in DNA gyrase, which code for 
subunits GyrA and GyrB respectively (ciprofloxacin’s secondary target in S. aureus) (Campion 
et al., 2004) (Ferrero et al., 1994) (Kelley et al., 1986) (Raviglione, et al., 1990). There are 
many SNPs associated with resistance, some causing amino acid changes in the enzyme 
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subunits, some not (Schmitz et al., 1998). Either way, these SNP’s allow for the prevention of 
ciprofloxacin binding to the topoisomerases. It would interesting to see how these synonymous 
mutations confer resistance and should be investigated further, with particular focus on the 
binding mechanism between the fluoroquinolones and the drug targets as it is still not clearly 
understood.  
Another mode of resistance to ciprofloxacin employed by S. aureus, is the utilisation of the 
efflux enzyme NorA (coded for by the gene norA), which can transport fluoroquinolones out 
of the cell (Campion et al., 2004). NorA is multidrug efflux pump and is coded for in the host’s 
chromosome but is only effective against ciprofloxacin when overexpressed. This can be 
achieved through mutations in the promotor region of norA which prevent repressor binding 
(Fàbrega et al., 2009). Multiple fluoroquinolone resistance mechanisms can be present in one 
organism and can be found in both methicilin resistant (MRSA) and methicilin susceptable S. 
aureus (MSSA) (Kwaatz & Seo, 1997). These mutations are not trasmitted horizontally but 
rather are the direct result of expsosure to the drug.  
 
2.4.4. Clindamycin 
Clindamycin is a lincosamide that can be used to treat some aerobic Gram-positive and some 
anaerobic Gram-negative bacteria (Smieja, 1998). Like most macrolides and streptogramin B 
class antibiotics, they bind to the 23S-rRNA receptor site of the 50S subunit of the ribosome, 
preventing protein synthesis, imparing the bacterium’s functionality (Bottega et al., 2014) 
(Leclercq, 2002). The most common form of resistance is most often associated with the 
presence of the genes ermA or ermC (Leclercq, 2002)(Yoon et al., 2008). It has also been noted 
that ermB can also be found in S. aureus but at a much lower frequency (Weisblum, 1995a). 
One study by Nicola et al., (1998) noted that one sample carrying the ermB gene showed strong 
constitutive resistance to erythromycin and clindamycin, however no other reports have been 
made except in other species including Streptococcus pneumoniae and Clostridium difficile 
(Waites et al., 2000; Pituch et al., 2003).  
These erm genes code for a specific methylation pattern, whereby an adenine (A2058) in a 
conserved region of domain V of the 23S rRNA receptor site is methylated, preventing binding 
of macrolides, lincosamides and streptogramin B antibiotics, causing the MLSB phenotype 
(Macrolide Lincosamide Streptogramin B resistance (Weisblum, 1995a; Levin et al., 2005). 
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This form of resistance prevents binding of the antibiotic. This is can result in constitutive 
resistance to clindamycin (cMLSB) or inducible resistance (iMLSB) which is induced when 
erythromycin resistant S. aureus (also coded for by erm genes) is in the presence of 
erythromycin (Siberry et al., 2003; Levin et al., 2005; Baragundi et al., 2013; Bottega et al., 
2014; Banik et al., 2015). Induced resistance will still be founded on the presence of an erm 
gene, but the expressed mRNA’s are inactive and cannot translate into protein, requiring a 
macrolide antibiotic to be present in order to induce the activation of said mRNA’s (Weisblum, 
1995b; Leclercq, 2002).  
This form of induced resistance is difficult to measure using broth dilutions or MIC’s as a two 
dimensional analysis would have to be carried out (increasing concentrations of clindamycin 
against increasing concentrations of erythromycin). A substantially easier way to test inducible 
resistance is to utilise the disc diffusion method by placing erythromycin and clindamycin discs 
adjacently. If the bacteria have the iMLSB phenotype then there will be no zone of clearing 
around erythromycin (erythromycin resistant) and a ‘D’-shaped zone of clearing around 
clindamycin (figure 2.9), thus indicating that the presence of erythromycin induces resistance 
to clindamycin. (Yoon et al., 2008) (Sasirekha et al., 2014). It has also been found that there 
are higher instances of clindamycin resistance (both constitutive and inducible) in MRSA 
isolates (68%-92% of MRSA isolates) than in MSSA (19%-30% of MSSA isolates) 
(Schreckenberger et al., 2004) (Yilmaz et al., 2007). 
 
Figure 2.9: Positive D-test result indicating an iMLSB phenotype (E – Erythromycin; CL – 
Clindamycin) (Levin et al., 2005) 
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2.4.5. Erythromycin 
Erythromycin is a macroide antibiotic used mostly for surface and soft tissue infections as well 
as other infections by a range of both Gram-negative and Gram-positive bacteria (Weisblum, 
1995a) it functions very similarly to clindamycin in that it targets the 23S rRNA receptor site 
on the 50S subunit of the ribosome in order to prevent protein synthesis (Leclercq, 2002). As 
previously mentioned, the most common forms of resistance to erythromycin comes from the 
host harbouring erm genes. S. aureus most commonly carries ermA and ermC genes which 
code for the enzymes that will methylate the sites on ribosomes where the antibitics bind in 
order to deactivate protein synthesis in the cell. Another previously mentioned gene, ermB, 
also confers erythromycin resistance but is not found as commonly as ermA and ermC (Nicola 
et al., 1998; Leclercq, 2002). There are other mechanisms of erythromycin resistance, a 
common one being the efflux of the antibiotics out of the cell before they are able to deactivate 
protein synthesis in the cell. This can be controlled by the msrA which codes for an efflux pump 
that resembles that of an ABC transporter, requiring 2 ATP-binding domains (Ross et al., 1990) 
(Leclercq, 2002). However, this mechanism only allows resistance to macrolides and 
streptogramin B antibiotics and not lincosamides like clindamycin (Baragundi et al., 2013).  
 
2.4.6. Gentamicin 
Gentamicin is effective as a broad spectrum antibiotic, and is often used as a stopgap while 
cultures determine the infecting pathogen (Mingeot-Leclercq et al., 1999). It belongs to the 
antibiotic class of aminoglycosides along with streptomycin, kanamycin A, amikacin, 
tobramycin and some others which are made up of a collection of various aminated sugars 
linked together, with glycosidic linkages to a cyclitol (Dowding, 1977; Mingeot-Leclercq et 
al., 1999; Xie et al., 2011a). These antibiotics are mostly used against Gram-negative bacteria 
but have broad spectrum capabilities. They work by binding to the 30S subunit of the ribosome, 
primarily, preventing the elongation of polypeptides as well as disabling the proofreading 
mechanism, thus interupting  and interfering with protein synthesis (Melancon et al., 1992; 
Mingeot-Leclercq et al., 1999). S. aureus’s resistance to this gentamicin usually extends to 
most aminoglycosides as the mechanisms entail the use of modifying enzymes that occur 
naturally in the cell, such as N-acetyltransferases (AAC) which disrupt amino functions and O-
nucleotidyltransferases (ANT) and O-phosphotransferases (AHP) which disrupt hydroxyl 
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functions (Figure 2.10) (Shaw et al., 1993). These all result in the inability of the antibiotic to 
bind to the ribosome.  
 
Figure 2.10: Sites of enzyme modification on gentimicin (adapted from Mingeot-Leclercq et 
al., 1999) 
The enzymes are named according to the site to which they target (Figure 2.6). In general, the 
genes coding for these enzymes are found on transposable elements such as plasmids, gene 
cassettes, integrons, genomic islands etc. and are transmissable within and between species. 
One in particular to S. aureus called aac(6’)-aph(2”) codes for bifunctional enzyme that targets 
2 sites with 2 different enzyme activities (Ramirez & Tolmasky, 2010). This gene is commonly 
found on transposons much like Tn4001 often found on plamids found in S. aureus (Mahairas 
et al., 1989). However, a study by Storrs et al., 1988 found that that gene could be found 
chromosomally. In this study, it was also determined that S. aureus isolates with high resistance 
to gentamicin only carried one copy of the gene, suggesting gene dosage is not a factor in how 
resistant an isolate is, therefore, considering the easy mode of transmission between bacteria 
and the strength of resistance from this common gene suggest a large risk associated with the 
use of gentamicin on S. aurues infections. While much information is available for these genes 
found in other species (particularly Gram-negative species) there is not much sequence 
information regarding those aminoglycoside-modifying enzymes found to be active in S. 
aureus specifically.  
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2.4.7. Linezolid 
Linezolid is the first oxazolidinone to be used as an antibiotic (Stevens et al., 2004). It is used 
to treat Gram-positive infections particularly skin and soft tissue infections by S. aureus, in 
particular, it is effective against vancomycin resistant strains of S. aureus (VRSA) (Endimiani 
et al., 2011). It has bacteristatic capabilities in that (like many other antibiotic classes) it inhibits 
protein synthesis and in doing so, prevents the cells from multiplying. However, this class of 
antibiotics is unique in that instead of preventing the elongation steps in protein synthesis, it 
prevents the initiation step of protein translation due to the molecule binding to the 23S rRNA 
subunit of the 50S unit of the ribosome, specifically, the catalytic site of the peptidyl-
transferase centre (see below) (Leach et al., 2011). Crosslinking experiments have shown that 
the antibiotic will bind in the peptidyl-transferase centre where the amino acid of the tRNA in 
the A position is situated (marked in blue in figure 2.11) (Leach et al., 2007). 
 
Figure 2.7: The first elongation step in protein synthesis. Oxazolidinones would bind at the 
peptidyl-transferase centre (white dotted circle) in the A position (blue square), preventing 
tRNAs from releasing their amino acids and preventing the formation of peptide bonds between 
amino acids (http://www.discoveryandinnovation.com/BIOL202/notes/lecture13.html edited 
and retrieved on 11 July 2016). 
Resistance to this antibiotic has been seen very rarely with more than 99.9% of S. aureus strains 
(MSSA and MRSA) are still susceptable to linezolid in the US alone and 99.8% are still 
susceptable globally (Jones et al., 2007a), (Jones et al., 2007b), (Mendes et al., 2008). 
However, in many cystic fibrosis patients, there have been an increase of instances of S. aureus 
acquiring resistance to linezolid after prolonged use in the patient (Endimiani et al., 2011). The 
Peptidyl-transferase centre 
50S subunit 
30S subunit 
mRNA 
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most recognised mechanism of linezolid resistance by S. aureus is a point mutation in domain 
V of the 23S rRNA genes.  
There are three distinct SNPs vis. G2576T, G2447T and T2500A. These mutations cause the 
23S rRNA to no longer be compatible with linezolid binding in the peptidyl-transferase centre. 
This domain V falls within the rrn rRNA operon of which S. aureus has five or six copies 
throughout the genome and it has been found that the more copies of these SNPs, the greater 
the resistance to linezolid (Besier et al., 2008). More SNPs in domain V have been documented 
more recently (Endimiani et al., 2011) suggesting that resistance to linezolid has been as a 
result of de novo mutations as a result of exposure and not horizontal transmittance. However, 
in 2010, it was documented that a plasmid mediated gene called cfr allowed S. aureus resistance 
to linezolid that is transmissable horizontally (Morales et al., 2010). This gene codes for a 
methyltransferase that methylates an adenine (A2503) situated in the 23S rRNA gene, which 
confers resistance to linezolid as well as other antimicrobials such ans chloramphenicols and 
clindamicin (Mendes et al., 2008).  
Now that linezolid resistance is transmissable, there is much pressure to find new effective 
therapies for cystic fibrosis pateints, and other patients with vancomycin resistant strains of S. 
aureus, as instances of resistance are likely to be more common. It is important that new 
methods of counter attack on linezolid resistant (particularly cfr carrying)  S. aureus that 
prevent resistance (e.g. chemical binding to cfr promotor to prevent its expression) be 
established soon as it is unwise to seek out other antibiotics that will eventually become 
redundant due to resistance as a result of overexposure.  
 
2.4.8. Tetracycline 
Tetracycline (the antibiotic) is grouped with doxycycline and minocycline in the class 
tetracyclines. These are broad spectrum antibiotics which reversably bind to the 30S subunit of 
the ribosome (unlike some previously mentioned protein synthesis inhibitors which bind on the 
50S subunit), sterically hindering incoming aminoacyl-tRNA’s at the A site, preventing the 
continuation of protein synthesis (figure 2.12) (Griffin et al., 2010).  
37 
 
 
Figure 2.12: Mechanism of action for tetracycline, preventing aminoacyl-tRNA’s from 
reaching the A site on the ribosome (image credit to Griffin et al., 2010) 
At the turn of the centuary tetracyclines were the second most prescribed broad spectrum 
antbiotic after penicillins and derivatives (Trzcinski et al., 2000), and as expected since then 
many cases of resistant S. aureus have arisen since then. Current knowledge suggests that there 
are 3 mechanisms of resistance to tetracyclines: expulsion of the antibiotic by use of efflux 
proteins, production of proteins that block tetracyclines from binding to the ribosome and the 
production of enzymes that metabolically inactivate tetracyclines (Ullah et al., 2012). The third 
has not yet been detected in Staphylococcal species (McCallum et al., 2010).  
Two common genes that code for efflux proteins, tetK and tetL are generally located on and 
acquired from plasmids, most commonly on the pT181 plasmid shown below (figure 2.13) 
(Noirot et al., 1990). These proteins will situate themselves within the cell membrane and 
actively (in an energy dependant manner) expel tetracycline molecules out of the cell so to 
prevent a toxic build-up within. tetK is more commonly seen in S. aureus than tetL, with tetL 
only being found in isolates already positive for tetM (Bismuth et al., 1990).  
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Figure 2.13: pT181 plasmid carrying tetracycline resistance gene tetK or tetL often acquired 
by S. aureus. Arrows within the diagram represent transcription direction. (Noirot et al., 1990).  
The most common gene coding for protein mediated ribosomal protection found in S. aureus 
is the tetM (tetO, another related gene is not commonly found in S. aureus). This gene is most 
commonly carried on transposons like Tn5801 and Tn916 (figure 2.14). These transposons also 
carry genes which allow for and regulate conjugation, meaning that the horizontal transfer of 
these elements is not limited by the capabilities of the hosting cell. Therefore, these transposons 
can indiscriminately move between different species of bacteria, making them powerful 
transport tools of antibiotic resistance (de Vries et al., 2009). Many MRSA isolates have been 
found with these genetic elements coding for various forms of tetracycline resistance, often 
carrying more that one tet gene.  
 
Figure 2.14: tetM carrying transposons Tn916 and Tn5801 with genes enconding conjugation. 
(de Vries et al., 2009). 
A recent study in Malaysia showed that MRSA isolates would often be found carrying such 
mobile genetic elements allowing for multiple drug resistances (Lim et al., 2012). Many tetM 
positive S. aureus isolates will be found carrying the tetK gene (the tetKM genotype) which as 
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additive effect to the tetracycline resistance of S. aureus (Trzcinski et al., 2000). What is not 
greatly understood is what affinities these elements have to each other and why it is common 
to find them in tandem. Understanding this may shed light on ways of preventing the spread 
and birth of more multidrug resistant strains of bacteria.  
 
2.4.9. Vancomycin and Teicoplanin 
These two glycopeptides have almost identical mechanisms of action and resistance but have 
been treated as separate antibiotics. Both have been used as effective antibiotics against MRSA, 
with vancomycin being the gold standard across the board for many years (Liu et al., 2011).  
Both have a glycopeptide core and work by inhibiting the production of crosslinkages in the 
cell wall, causing the osmotic pressure of the inside of the cell to be too high for what the cell 
wall with weakened integrity can hold, resulting in the lysis of the cell (Hiramatsu, 2001) 
(Somma et al., 1984). The glycopeptides do this by hydrogen bonding to the D-alanyl-D-
alanine peptide group on the end of N-acetylmuramic acid (NAM) moeities, preventing 
crosslinking enzymes from securing the pentaglycine chain on the NAM moeity to the D-
alanine on other NAM molecules (figure 2.15). Because these glycopeptides target such a vital 
molecule (peptidoglycan) in the cell and not the enzymes that build them, there has (until 
recently) been very little wiggle room for the bacteria to change the substrate to which the 
glycopeptides bind, meaning that binding affinities between the antibiotic and the substrate do 
not dictate the antimicrobial activity of the antibiotic in susceptable bacteria (Courvalin, 2006).  
In understanding that vancomycin and teicoplanin have the same mechanisms of action, it 
stands to reason that resistance mechanisms would affect them both. Resistance to vancomycin 
and teicoplanin is mediated by the same group of genes. These van genes are suspected to have 
originated from Enterococcus sp. and moved to S. aureus strains (Moellering, 2006). Initially 
only vanA clusters had been identified in S. aureus (Courvalin, 2006), but a more recent study 
in Iran showed that vanB clusters were identified in 37% of screened isolates (Saadat et al., 
2014). There are other van gene clusters but are only found in enterococci and other Gram-
positive or intrinsically resistant species. vanA is found on Tn1546-like transposons, originally 
non-cojugative elements, but also on some plasmids and occasionally, chromosomally 
(Périchon & Courvalin, 2009). vanB gene clusters are found on transposable elements that can 
conjugatively move between chromosomes, as well as on Tn916-like transposons. Both gene 
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clusters produce enzymes that work toward replacing the terminal D-alanine of  NAM with a 
D-lactate, derived from reduced pyruvate, thus preventing glycopeptides with hydrogen 
bonding and interupting cell wall synthesis (Figure 2.15). vanA permits high resistances to 
vancomycin and teicoplanin while vanB has a less clearly described intensity of resistance to 
either antibiotic when in expressed in S. aureus. However, in enterococci it has been noted that 
vanB resistance is inducible only in the presence of vancomycin and so has been noted to confer 
“variable” resistance (Courvalin, 2006). More research should be conducted to clearly define 
the resitance profiles vanB allows for in S. aureus. Good news came in 2011 when a redesigned 
form of vancomycin was developed that could bind to D-alanyl-D-lactate and D-alanyl-D-
alanine subtrates, allowing it to be effective against isolates previously identified as 
glycopeptide resistant as well as those that are currently identified as susceptible (Xie et al., 
2011b).  
 
Figure 2.15: Sequence of events when cell wall synthesis is interrupted by glycopeptide 
antibiotics (vancomycin is shown but mechanism applies to teicoplanin as well). Top line 
illustrates events when no resistance mechanisms present and the bottom line illustrates events 
when resistance mechanisms are present 
There are other types of resistance not mediated by van gene clusters has been described, 
usually in S. aureus isolates with profiles of intermediate resistance and an unknown 
mechanism of resistance (strains like Mu50). One strain has even been isolated that produces 
colonies with varying levels of resistance when subcultured, known as heterogenous resistance 
(strain Mu3) (Sujatha & Praharaj, 2012). More and more MRSA isolates have been acquiring 
glycopeptide resistance, predominantly through the acquisition of the vanA gene cluster most 
probably from vancomycin resistant enterococci (VRE) co-infecting a wound, but some 
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isolates are showing intermediate resistance without vanA. Most literature has found that in 
VR-MRSA, disc diffusion does not accurately detect the resistance profile and that minimum 
inhibitory concentration tests should be utilised instead (Loomba et al., 2010; Thati et al., 
2011). More research needs to be conducted on the relationships between haboured genes and 
resistance profiles, both for vancomycin and teicoplanin and the mechanims by which MRSA 
and MSSA with intermediate and heterogenous resistance act. Also, investigating ways of 
preventing conjugation between VRE and S. aureus may prove useful in finding ways reducing 
the rate of van gene acquisition.  
 
2.5. Isolation Media for S. aureus 
It is not an unknown fact that genetic characterisation is the most reliable method for accurately 
determining the species of an organism (Brakstad et al., 1992; DeAngelis et al., 2011; Shalaby 
et al., 2011). It even has the power to differentiate individuals within a species that would 
phenotypically have been characterised as the same (sub-species within a species). In 
bacteriology, there is much need for genetic species confirmation in both research and clinical 
or diagnostic settings due to the ubiquitous nature of bacteria, our inability to distinguish them 
by visual characteristics, regardless of the magnification used to view them and the fact that 
genetic methods are far more rapid which is especially important for clinical diagnostic 
purposes. Unfortunately, most DNA related methods, such as conventional PCR, PFGE, 
sequencing and RAPD techniques, require expensive equipment as well as a high reagent 
expense per sample (Spiegelman et al., 2005). As a result, many biotechnology companies have 
attempted to develop growth media which select against particular groups of bacteria (based 
on biochemical charateristics) in order to allow unhindered growth of another group of bacteria 
(based on other biochemical characteristics), so to reduce the number of samples required to 
undergo genetic testing by presumptively eliminating samples that do not have the microbe of 
interest.  
This is not just important in order to reduce costs needed in clinical diagnostics or research, but 
also to ensure accurate detection of the microbe of interest. In the environment, there are a large 
range of microbes which exist together, including bacteria, fungi, viruses, archaea and other 
single cell eukaryotes. Like most natural habitats, there is much competition between species 
for space and food meaning that, unlike in a laboratory setting, there is a lot of pressure against 
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the survival of most individual species (Hibbing et al., 2010; Foster & Bell, 2012). Selective 
media offer to eliminate some, if not all, competition against the microbe of interest in order to 
allow it to grow in such a manner appropriate for its detection and downstream processing 
(Ehrmann et al., 2013).  
It can often happen that in an environmental sample, even when subjected to selective media, 
the microbe of interest may still have its growth masked or inhibited by other microbes present 
that survive in similar selective conditions (Gostinčar et al., 2009). This makes it important to 
choose the appropriate medium for the purposes of ones study. A number of studies have 
investigated the benefits of using more specifically selective media (examples discussed below) 
when working with environmental samples specifically, finding that media tailored to inhibit 
wider ranges of microbes produce more sensitive and accurate results but DNA methods are 
required to confirm presumptive results.  
Discussed below are some examples of different media used for the isolation of S. aureus, their 
composition, how they eliminate competition and the characteristics they confer onto positive 
S. aureus samples.  
 
2.5.1. Enrichment Media 
2.5.1.1. Buffered Peptone Water 
Peptone water is a very simple enrichment medium made of 2 parts peptic digest of animal 
tissues (provides essential nutrients) and 1 part sodium chloride (maintains osmotic balance) 
(HiMedia, 2011). Buffered peptone water has added anhydrous disodium phosphate and 
monopotassium phosphate to allow it buffering capabilites (HiMedia, 2017). Both allow for 
the enrichment of sampled microbes for appropriate analysis in selective media but buffered 
peptone water offers recovery sub-lethally damaged cells which may be sensitive to 
fluctuations in pH. This makes it possible also to recover live cells from older laboratory 
samples (as many as 10 weeks old) that were left in normal sterile storage conditions (4°C 
refrigerators), that would appear unviable if directly subcultured onto selective media. As 
environmental samples can carry whole niches of micro-organisms, it is not unusual to have 
some difficulty detecting your microbe of interest due to all the competitive stressors it has had 
to endure (Hibbing et al., 2010; Edel & Kampelmacher, 1973). This makes normal and buffered 
peptone water, despite their simplicity, important for pre-enrichment, prior to selection. With 
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regard to this study, this is a very important step as S. aureus is not often found as the majority 
of a microbial population within the airways of dogs, which if not properly pre-enriched, may 
be overcome by the competition of other microbes, making it too difficult for it to grow on 
selective media, resulting in it remaining undetected and the sample exhibiting a false-negative 
result. The peptone waters, in their simplicity, can have agents added to them which can be 
selective or differential such as phenol red (pH indicator) for detecting carbohydrate 
fermentation or EC O157: H7 Selective Supplement for the selection of Escherichia coli O157. 
This is most appropriate for tests on already isolated microbes that are in need of biochemical 
testing.  
 
2.5.1.2. Tryptone Soy Broth (TSB) 
TSB contains pancreatic digest of casein and papaic digest of soyabean meal to provide amino 
acids and other longer chained peptides required for microbial growth. The carbohydrate source 
is dextrose sugar and dibasic potassium phosphate acts as the buffer for the medium. NaCl 
maintains the osmotic balance (HiMedia, 2011). This is used as a non-specific general growth 
medium for most aerobic bacteria and fungi and as such can be used for sterility testing of other 
media. As such, this medium is not recommended for use with environmental samples when 
isolation of a specific species is the intended goal. However, once your species of interest is 
successfully isolated, it may be re-cultured successfully for downstream microbial techniques 
such as antimicrobial susceptibility testing.  
 
2.5.1.3. Columbia Blood Agar (CBA) 
CBA is a particularly versatile base medium that can be used for both selective and differential 
purposes. It is composed mainly of special peptone – a nutrious substance promoting rapid 
growth of most types of bacteria. It also uses corn starch is primarily a carbohydrate source 
which doubles as a natural neutraliser of toxic metabolites (HiMedia, 2011a). As it is a base 
medium, a range of additives can be used to differentiate different species of bacteria and some 
to inhibit the growth of others. For the isolation of S. aureus, one selective suppliment that can 
be added to the medium is a combination of two antibiotics that have primary action against 
Gram-negative bacteria, usually nalidixic acid and colistin sulphate (HiMedia, 2012). This 
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gives the Gram-positive bacteria such as those in the Staphyloccocus species less competition 
when growing on the medium, allowing S. aureus species to be detected more easily. The 
addition of sheeps’ blood can allow the researcher differentiation between species which are 
capable of α-, β- and γ-haemolysis and those incapable (Ellner et al., 1966). S. aureus has α- 
and β-haemolytic capabilities and such can be distiguished from other species, if it is already 
known to be in the sample. However, as it has been discussed above, S. aureus’s β-haemolysin 
gene hlb can be interupted and rendered inexpressive by the insertion of phage DNA within 
the gene. Such samples would appear as only α-haemolytic and since the medium does not 
offer other differentiating factors, the sample would be overlooked as a negative result.  
 
2.5.2. High Salt Media 
2.5.2.1. Mannitol Salt Agar (MSA) 
MSA is currently the go-to medium for growth of S. aureus and is the recommended medium 
by the Korean Food and Drug Administration (KFDA) (Kim & Oh, 2010) and is widely 
understood to especially suit the growth conditions required by Staphylococcus sp. and other 
cocci. This medium is both selective and differential. For selection, MSA contains high salt 
concentrations which usually only Staphylococci can survive in. . For differentiation, MSA 
also offers D-mannitol as a carbohydrate source. D-mannitol if fermented creates excess acid. 
Phenol red in the medium differentiates between fermenters and non-fermenters by changing 
to yellow in the presence of an acidic environment (HiMedia, 2015).  However, there are a few 
species of bacteria such as S. xylosus, S. cohnii, S. sciuri, S. simulans and Listeria spp, among 
many others, that are able to ferment D-mannitol and produce a positive phenol reaction, if 
they can survive the high salt concentrations. As a result, it is recommended that a secondary 
coagulase test ought to be carried out in order to confirm that presumptive colonies are indeed 
S. aureus (Gramoli & Wilkinson, 1978). Many fungi are also able to survive in moderately 
saline environments such as Cladosporium sphaerospermum, its spores very commonly found 
in indoor and outdoor air (Gostinčar et al., 2009), and so, likely to be found in the airways of 
most animals. This means that MSA can will only be accurate in presumtively identifying S. 
aureus depending on where or what is sampled.  
Kim and Oh, (2010) demonstrated that MSA was 96.5% sensitive (S. aureus-positive samples 
were correctly identified) and 66.6% specific (S. aureus-negative samples were correctly 
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identified) when isolating from innoculated commercial food. However, Niskanen and Aalto 
(1978), originally demonstrated that MSA was 88% sensitive and 75.4% specific at detecting 
S. aureus from innoculated minced meat. Both of these studies used set innoculants which do 
not accurately represent the biological balances in an environmental sample. This is not to say 
that MSA has not been used for direct direct selection from environmental samples. In 2006, a 
study by Sexton et al. involved sampling surfaces and air in MRSA isolation wards in a hospital 
directly with MSA. While many studies have discussed the imperfect results produced by MSA 
when many different species are involved in a sample, that factor may have been reduced be 
the fact that surfaces in these isolation rooms had vigourous sterilisation routines that should 
eliminate much of the unwanted competition that would be seen under normal circumstances. 
Thus, careful consideration should be given when deciding on a medium for use in a study, if 
environmental samples are to be used. More studies measuring the accuracy (sensitivity and 
specifity) of MSA (and other media) for different types of environmental samples should be 
conducted to standardise the appropriateness of media used, depending on the context of the 
study.  
 
2.5.2.2. Staphylococcus Agar No. 110 (SA No.110) 
Also known as Stone Gelatine Agar, SA No.110 is a differential medium for staphylococcal 
species that also uses D-mannitol reduction as a manner of intial differentiation. Like MSA, it 
selects against other species by use of high salt conentration. It uses casein enzymic hydrolysate 
and yeast extract as sources of carbon, nitrogen and other essential nutrients and growth factors 
but it also includes D-mannitol and lactose as corbohydrate sources as well. Unlike MSA, SA 
No.110 does not use phenol red as an indicator for mannitol reduction. It also includes gelatin 
which S. aureus is able to digest. These two factors and the colony pigmentation are the 
differential factors in this medium. Therefore, if an isolate survives on the medium, reduces 
the mannitol, digests the gelatin, and has yellow to orange coloured colonies, it may be 
presumptively be considered, S. aureus (HiMedia, 2015). However, the limitations of this 
medium are the same as MSA: while SA No.110 has greater differential power (more 
differentiating factors are included), it has the same selective power as MSA – any halotolerant 
species can survive on this medium. This potentially allows for the masking of true S. aureus 
isolates by other microbes, depending on the competitive dynamics in the sample.  
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2.5.3. Potassium Tellurite Media 
2.5.3.1. Vogel-Johnson Agar (VJA) 
VJA is a slightly involved medium that uses the addition of a number of selective agents in the 
agar, including potassium tellurite as its main selective agent as opposed to the high salt 
concentrations used in MSA and SA No.110. VJA is both a selective and differential medium. 
Apart from the basic nutritional components, it includes glycine, lithium chloride and 
potassium tellurite (1%) as selective agents. Glycine, in high enough concentrations, inhibits 
the growth of most bacteria due to interference with cell wall synthesis enzymes (Cowles, 1947; 
Minami et al., 2004), but due to their reinforced cell walls, Gram-positive bacteria can survive 
the higher concentrations. Lithium chloride also acts as an inhibitor towards non-Gram-positive 
microflora as coagulase-positive Staphylococcus sp. (CoPS) have specially adapted cell walls 
that prevent the intake of lithium chloride. Potassium tellurite when reduced enzymatically 
produces a superoxidative free-radical that has toxic effects on most microflora, however, 
CoPS can survive the superoxidatitive effects and continue to reduction pathway to finally form 
metallic tellurium (Pérez et al., 2007). Due to all these inhibiting agents, D-mannitol, is added 
which acts to promote S. aureus growth. Differentiating factors are phenol red and potassium 
tellurite, therefore mannitol fermenters turn the agar yellow, and potassium tellurite reducing 
colonies will be black due to tellurium deposits (HiMedia, 2016). The high selectivity of this 
media allows it to be used for the detection of CoPS in highly contaminated food and clinical 
samples. It is also approved by the American FDA (Kim & Oh, 2010). This medium scored 
88% sensitive and 31% specific in Niskanen and Aalto’s innoculated minced meat in 1978, but 
100% specificitiy and sensitivity in Hyun-Jung and Se-Wook’s innoculated rice and fish in 
2010. This little more than prove that this medium’s ability to accurately detect S. aureus 
depends more on the type of sample used than the medium itself, and that neither of these 
results indicate its reliability for environmental samples.  
 
2.5.3.2. Baird-Parker Agar (BPA) 
BPA is very similar to VJA except that it does not use D-mannitol and it also uses a higher 
concentration of potassium tellurite (3.5%) (HiMedia, 2015). It also uses stabilised egg-yolk to 
detect lipase activity exibited by some CoPS species such as S. aureus and S. intermedius 
(Hájek, 1976). D-mannitol is not as selective as the potassium tellurite and as such, is not 
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necessary. The increased concentration of potassium tellurite selects against most other 
microbes completely except CoPS. With the increased stringency in  selection there are fewer 
and fewer instances where S. aureus might be overlooked or masked by contaminating species 
and as a result it has become the most recommended medium for isolation of S. aureus from 
food, clinical and industrial samples by the KFDA, American FDA, Association of Official 
Agricultural Chemists (AOAC) and Association Francaise de Normalisation Standards 
Organization of France (AFNOR) (Kim & Oh, 2010). In both the Kim and Oh (2010) and the 
Niskanen and Aalto (1978) studies, it was the most accurate medium that could sensitively 
detect S. aureus at all concentrations.  
 
2.5.3.3. HiCrome Aureus Agar Base (AAB) 
AAB is very similar to BPA except that it is chromogenic and the nutrient sources are slightly 
different (does not affect nutrient composition). AAB also lacks glycine. With high potassium 
tellurite concentrations like BPA (3.5%), glycine is likely an unnecessary selective agent 
(HiMedia, 2015). Same colony morphologies are expected on AAB as are on BPA except that 
Listeria monocytogenes will appear a deep blue, differentiating it from the CoPS. This medium 
is recommended for the use for environmental samples by the product’s company but there is 
little literature that demonstrates this as such.  
 
2.5.4. Other Chromogenic Media 
2.5.4.1. CHROMagarTM staph aureus 
This medium uses similar components to BPA when supplimented with rabbit plasma 
fibrogenin but also includes a mixture of chromegenic components that allow differentiation 
between a number of different species (AOAC Research Institute, 2016). This medium does 
not offer a greater selective power than other media, only the convenience of easier 
differentiation between colonies.  
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2.6. Conclusion 
Staphylococcus aureus is of great scientific interest due to its potential for disease governed by 
its wide range of virulence mechanisms, antibiotic resistance mechanisms (summerised in 
Table 2.3) and its ability to survive in a range of environments. Both its commensal and 
pathogenic nature are what make it so dangerous, allowing it to be widespread throughout 
human populations while remaining asymptomatic, waiting to take an opportunity to cause 
sometimes life-threatening disease (Corey, 2005). While decades of research has been done on 
this organism, and there are abundnant sources of information on it, its pathogenicity and its 
genome, there are still some gaps in knowledge, both of the organism’s mechanisms of action 
in particular stages of infection and of effective treatments that limit the pathogen’s virulence 
(as opposed to poisoning it with antibiotics which can be dangerous to the patient involved as 
well). As such we still find ourselves encountering untreatable epidemics of multidrug resistant 
S. aureus, suggesting that implementation of ourknowledge of this microbe is not being utilised 
to its full potential.  
Beyond this, it is important to recognise that while new treatments take a while to develop and 
test, it is extremely important to manage and contain epidemics that happen in the mean time 
and that must be done through careful monitoring of carrier populations where S. aureus can 
thrive asymptomatically until disease is caused. Literature has highlighted that dogs have the 
potential to be carriers and observation of their domestic populations could prove useful in 
preventing infection in humans. As S. aureus virulence is not tailored to canine immune 
systems (Boost et al., 2008), appropriate and sensitive methods should be utilised to generate 
the most accurate population representative data. Comparitive studies of isolation and detection 
methods may prove useful for future survellence studies.   
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Table 2.3: Antibiotic resistance observed in S. aureus and the mechanisms of resistance 
acquisition.  
Antibiotic Class Gene Resistance 
acquisition 
Reference 
Cefoxatin Cephamycin mecA SCCmec Tsubakishita et 
al., 2010 
Ceftoroline Cephalosporin Y446N and E447K in mecA Exposure Long et al., 2014 
Ciprofloxacin Fluoroquinolone SNPs in grlA and glrB 
 
Overexpression of norA 
Exposure 
 
Exposure 
Campion et al., 
2004 
Fàbrega et al., 
2009 
Clindamycin Lincosamide ermA 
 
ermC 
Tn554 
 
Plasmid 
Murphy et al., 
1985) 
Westh et al., 1995 
Erythromycin Macrolide ermA 
 
ermB 
 
 
ermC 
msrA 
Tn554 
 
Tn1545, 
Tn917 
Plasmid 
Plasmid 
Plasmid 
Murphy et al., 
1985 
Okitsu et al., 
2005 
Li et al., 2016 
Westh et al., 1995 
Matsuoka et al., 
1998 
Gentamicin Aminoglycoside aac(6’)-aph(2”) Tn4001 Mahairas et al., 
1989 
Linezolid Oxazolidinone SNPs in 23S rRNA genes 
 
cfr 
Exposure 
 
Plasmid 
Endimiani et al., 
2011 
Morales et al., 
2010 
Teicoplanin 
& 
Vancomycin 
Glycopeptide vanA 
 
vanB 
Tn1546-like 
 
Tn916-like 
Périchon & 
Courvalin, 2009 
Courvalin, 2006 
Tetracycline Tetracycline tetK 
tetM 
pT181 
Tn5801, 
Tn916 
Noirot et al., 1990 
de Vries et al., 
2009 
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CHAPTER 3 
 
COMPARISON OF MANNITOL SALT AGAR AND HICROMETM AUREUS AGAR 
BASE FOR THEIR POWER IN SELECTING FOR S. aureus FROM 
ENVIRONMENTAL SAMPLES (DOG NARES) 
3.1. Abstract 
Mannitol Salt Agar (MSA) is the standard selective medium used for S. aureus. However, it 
allows growth for many halotolerant microbes. S. aureus is not the most prevalent 
Staphylococcal species in dogs and is under much competitive pressure in order to survive, 
making it a delicate organism to isolate in this context. This investigation aimed to test if MSA 
was sensitive and selectively powerful enough to isolate S. aureus from dog nasal swabs as 
compared to HiCromeTM Aureus Agar Base (AAB) which is assumed to be more suitable for 
environmental samples. 56 samples were collected and placed in peptone water and their true 
state of S. aureus presence was determined by directly testing for S. aureus specific gene nuc. 
Each sample was plated onto both MSA and AAB and presumptive results were confirmed 
with detection of nuc. Presumptive and nuc results were compared to the true states of each 
sample so to measure the sensitivity, % of type I errors due to poor selective power and 
accuracy of true state prediction in conjunction with nuc testing of each media. MSA was 
60.9% sensitive, 60% of type I errors due to poor selective power and 84% accurate in true 
state prediction. AAB was 95.7%, 0% and 98.2% respectively. Odds ratios determined AAB 
as 14.08 times more likely to detect S. aureus from dog nare samples than MSA. This suggests 
that MSA is not suitable for the context of S. aureus isolation from dogs and that previous 
prevalence rates may be underestimated by as much as 60%.  
KEYWORDS: Staphylococcus aureus, Selective Media Comparitive Analysis, Mannitol Salt Agar, 
HicromeTM Aureus Agar Base, Environmental Samples, Dog 
 
3.2. Introduction 
Staphylococcus aureus is both a commensal and pathogenic organism that can survive within 
a range of hosts and habitats (Kluytmans et al., 1997; Public Health Agency of Canada, 2011). 
It is of special interest to many researchers involved with healthcare and disease due to the 
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microbes’ unique abilities to evade the human immune system to cause disease in conjunction 
with its rising prevalence of resistance to all classes of antibiotics used against it (Leclercq, 
2002; Campion et al., 2004; Courvalin, 2006; Yoon et al., 2008; Ramirez & Tolmasky, 2010; 
Tsubakishita et al., 2010; Endimiani et al., 2011; Liu et al., 2011; Lim et al., 2012; Long et al., 
2014; Banik et al., 2015).  
Dogs, a proven carrier of S. aureus, are not subject to the same virulence demonstrated by S. 
aureus in humans as S. aureus’s virulence is tailored specifically to the human immune system 
(van Duijkeren et al., 2011; Garbacz et al., 2013). Their risk as asymptomatic carriers of 
virulent S. aureus that can reinfect humans has also been observed (Manian, 2003; van 
Duijkeren et al., 2005). This demonstrates the importance of observing S. aureus, its prevalence 
and the prevalence of carried antibiotic resistance and virulence genes in reservior populations 
like dogs very important. In studies by Boost et al. (2008) and others, dogs are sampled from 
the the nares which are home to many different competing microbes, as like most 
environmental samples (Hibbing et al., 2010; Foster & Bell, 2012). However, since S. aureus 
is not as virulent in dogs, it is already at a competitive disadvantage, meaning their cell count 
will be much lower than that in a human sample. This can be problematic for laboratory 
methods that may not be sensitive enough to detect S. aureus in such a competitive environment 
and as such, the most appropriate methods must be carefully chosen in order to produce the 
most accurate results.  
Mannitol Salt Agar (MSA), the most widely used laboratory medium for S. aureus and is the 
recommended medium by the Korean Food and Drug Administration (KFDA) (Kim & Oh, 
2010). This medium is both selective in that it restricts growth to only halotolerant microbes 
(can survive in high salt conditions but are not essential for growth) and differential in that 
mannitol fermentation causes the medium to change colour from red to yellow (HiMedia, 
2015).  These criteria are not specific, allowing the likes of S. xylosus, S. cohnii, S. sciuri, S. 
simulans, Listeria spp and even very common airbourne fungi like Cladosporium 
sphaerospermum, among many others, to grow and produce a positive colour change, 
mimicking the growth of S. aureus (Gramoli & Wilkinson, 1978; Gostinčar et al., 2009). 
Studies by Nisakanen and Aalto (1978) and Kim and Oh (2010) demonstrated this lack of 
specificity (75.4% and 66.6%, repectively) from controlled, innoculated samples. With MSA’s 
lack of specificity and samples taken from environments with a lot of competition against S. 
aureus, MSA may not be the appropriate medium for the isolation of S. aureus, specifically 
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from dog nares, i.e. it is hypothesised that the sensitivity of a medium will change depending 
on the type of samples innoculated on to it.  
An alternative to mannitol fermenting media are the potassium tellurite reducing media like 
HiCromeTM Aureus Agar Base (AAB) and Baird-Parker Agar (BPA). AAB differs from BPA 
in that it is chromogenic (can differentiate Listeria monocytogenes from coagulase positive 
Staphylococci (CoPS) when grown on AAB) and the nutrient sources are slightly different 
(does not affect nutrient composition) (HiMedia, 2015). These types of media theoretically 
have a much higher selective power than mannitol fermenting media as their components select 
against a much broader rage of environmental microbes including non-Gram positive microbes 
(Gram-negative bacteria, fungi and other microbes) and other coagulase-negative 
Staphylococci (CoNS) by using potassium tellurite and lithium chloride (Pérez et al., 2007). 
The only limitation this medium would have in the context of sampling from dog nares is that 
S. pseudointermedius, the most abundant Gram-positive microbe in dog airways, can present 
similarly to S. aureus as it has many of the features of S. aureus that this medium was designed 
around (i.e. survives under superoxidative stress and cell wall refrains from taking up lithium 
chloride) (Hájek, 1976; Hoekstra & Paulton, 2002; Hanselman et al., 2009). This medium is 
recommended for the use for environmental samples by the product’s company but there is 
little literature that demonstrates this as such.  
The aim of this studyproject was to detect the true state (difinitive presence or absence of S. 
aureus) of an environmental sample (dog nare swab) by use of genetic methods and then 
comparing presumptive results from MSA and AAB to them, so to demonstrate the sensitivity 
and specificity of Mannitol Salt Agar and HiCrome Aureus Agar Base in specific context of 
dog nare samples, without the biases of designing an experiment with innoculated samples.  
 
3.3. Materials and Methods 
Sample collection 
Between January and June 2017, samples were taken from 56 dogs housed at a veterinary 
hospital located in Westville, Durban, (50 pets in for various degrees of veterinary care, 6 were 
strays left with the clinic to undergo primary care in order to bring the animals to adoption 
appropriate health) from the nares. They were collected using sterile cotton swabs dipped in 
autoclaved deionised water.  
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Enrichment 
Each swab was placed into 5ml of autoclaved peptone water and incubated at 37°C for 18-
24hrs before selection. This step is used to help recover and condition cells, damaged from 
environmental and competitive stress to avoid false negatives (Hibbing et al., 2010; HiMedia 
2017).  
Selection 
Sigma-Aldrich’s HiCromeTM Aureus Agar Base (AAB) supplemented with the equivalent of 
3.5% potassium tellurite but without egg yolk emulsion. This was because the egg yolk 
emulsion (EYE) would not be able to differentiate between S. aureus and S. intermedius, which 
is more common in dogs. Since it is very expensive it was decided that its omission would be 
of little consequence to the project. MSA bought from Oxoid and was made according to 
product instructions. Onto 60mm plates of AAB and MSA each, 100µl of peptone water culture 
was spread plated and then incubated at 37°C for 18-24hrs. If plates were overgrown, a second 
spread plate was performed using a 10-1 or 10-2 dilution of peptone water, as necessary. For 
MSA, pale yellow-gold colonies were picked up and isolated on a second 60mm MSA plate 
using the 4-way streak method and then incubated at 37°C 24hrs (Figure 6.3.1, see Appendix). 
For AAB, very shiny black colonies were picked up and isolated on a second 60mm AAB plate 
using the 4-way streak method and then incubated at 37°C for 36-48hrs (Figure 6.3.2, see 
Appendix). Any plates which had fungal growth with otherwise no presumptive bacterial 
characteristics were considered a negative presumptive result.  
DNA isolation 
True State testing: On the same day peptone water culture was inoculated onto each medium, 
a total of 2ml of said culture was spun down at 15 000xg. Supernatant was removed leaving 
cells for lysis. 500µl sterile water at 4°C was added to the cells and then vigorously vortexed 
for 2 minutes, to dislodge the pellet and break the cells. 500µl of 24:1 chloroform and isoamyl 
alcohol was added at 4°C and vortexed again until the mixture appeared somewhat 
homogenous. Tubes were then spun down at 12 000xg for 5 minutes. The top aqueous layer 
was removed into a clean tube. The DNA concentration was measured using NanoDrop 
technology and diluted as necessary for concentrations appropriate for PCR (approximately 
5µM) and then stored at -20°C until PCR.  
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Media testing: Individual colonies from the presumptively positive 4-way streak plates were 
picked up using an inoculation loop and broken up into 500µl sterile water at 4°C. Then added 
was 500µl of 24:1 chloroform and isoamyl alcohol at 4°C. Tubes were vortexed and 
centrifuged at 10 000xg for 5 min. The top aqueous layer was used directly in PCR (Ruiz-
Barba et al., 2005).  
PCR detection of nuc 
In 12.5µl of ThermoFisher’s DreamTaq® Green PCR master mix (2x), was used with 4µl of 
the extracted DNA supernatant. 4 µM of each primer synthesised by Inqaba Biotech were used 
(Forward: 5’-GCGATTGATGGTGATACGGTT-3’; Reverse: 5’-
AGCCAAGCCTTGACGAACTAAAGC-3’, respectively (Brakstad et al., 1992)) and the 
reactions were made up to 25µl using sterile nuclease free water. Cycling conditions were 
initial denaturation at 94°C for 4 minutes then 40 cycles of 94°C for 1 minute, 56.5°C for 30 
seconds and 72°C for 1 minute and 30 seconds and then final extension of 72°C for 3 minutes 
and 30 seconds. To maintain objectivity, nuc detection in DNA from the peptone cultures was 
not carried out until after DNA isolated from selected cells from each medium was tested. True 
State was determined by the presence or absence of nuc from the peptone cultures.  
Gel electrophoresis 
All products were run through 1.5% agarose gels stained with ethidium bromide at 80V until 
the loading dye provided by the master mix was ~1cm from the bottom. A representative image 
is provided below (Figure 3.1).  
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Figure 3.1: Expected product for a positive nuc result (Lanes: 
1 – 100bp ladder; 2 – 50bp ladder; 3 – nuc) 
Statistical Analyses 
All samples had to be classified according to how their presumptive results related to the true 
state in order to appropriately draw context to how each media performed in its selection.  
True State: S. aureus predetermined as Present 
• True positive – A positive presumptive and nuc  
• False negative (type II error) – A negative presumptive and nuc. This included 
plates with no growth.  
• False false positive (type I error) – A positive presumptive and negative nuc (i.e. 
S. aureus was present in the sample but the presumptive characteristics which 
manifested were of another species present and so nuc testing produced a 
negative result, more simply put, the medium’s prediction was correct, but it 
was based on the biochemical activity of the wrong organism). Inclusion of this 
fifth category is to show the biological context of this data. However, to 
calculate the Odds Ratio (OR), for statistical purposes, these cases must be 
grouped with false negatives.  
True State: S. aureus predetermined as Absent 
• False positive (type I error) – A positive presumptive with negative nuc 
• True negative – A negative presumptive and nuc. This also included plates with 
no growth, i.e. complete and successful selection took place. 
250bp 
500bp 
1kbp 
270bp 
1 2 3 
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Sensitivity was calculated for each medium as the proportion of true positives out of the total 
number of samples where S. aureus was predetermined as present. Similarly, Specificity was 
calculated for each medium as the proportion of true negatives out of the total number of 
samples where S. aureus was predetermined as absent. To demonstrate the difference in results 
error rates, the χ2 value was calculated using IBM® SPSS® Statistics, version 24. Odds ratios 
were calculated for each medium, considering false false positives and false negatives together. 
Crosstabulation oriented the True State of S. aureus as the baseline factor and the medium’s 
ability to provide a true or false result as the outcome, i.e. when using the formula OR = 
(a*d)/(b*c), a = number of True Positives, b = the number of False Negatives, c = the number 
of True Negatives and d = the number of False Positives (Szumilas, 2010).  
 
3.4. Results and Discussion 
Of the 56 samples tested, 23 had S. aureus present and 33 absent (True State). The graph below 
shows the results of selection with both media.  
Figure 3.2: Histogram to show frequencies of selection results. Percentages 
(%) are shown above each bar (MSA – Mannitol Salt Agar; AAB – 
HiCromeTM Aureus Agar Base) 
To truly understand the implications of these results, they must be discussed according to the 
medium’s presumptive accuracy and medium’s sensitivity with nuc confirmation:  
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Without the use of nuc for confirmation (based only on presumptive medium results), MSA 
was 58.3% accurate in its presumptive predictions of S. aureus being present (percentage of 
true positives out of all presumptively present cases). The remaining 41.7% (type I error) was 
attributable to the medium’s inbility to eliminate competition masking S. aureus 60% of the 
time (% of false false positives out of erroneous presumptively present cases) and its inability 
to differentiate between isolates 40% of the time (% false positives out of all erroneous 
presumptively present cases). AAB was 56.4% accurate in its presumptive predictions S. 
aureus being present, with all error being attributable to a lack of differential capabilities in 
the medium (100% of error due to false positives), with no incidences of S. aureus being 
masked by competition. On this score, AAB already proves its capabilities as a more powerful 
selective medium than MSA.  
This is reiterated when nuc is used in conjunction with the medium to confirm isolates as 
S. aureus. MSA was found to be 60.9% sensitive while AAB was 95.7% sensitive. 
Specificities were calculated as 87.9% for MSA and 48.5% for AAB.  Low rates of specificity 
for AAB are purely related to poor differential ability on its own, due to S. pseudointermedius 
being present more often in canines than S. aureus and presenting similar colony morphology 
(Hoekstra & Paulton, 2002). Differential capabilities can always be adjusted with the addition 
of differentiating reagents such as egg yolk emulsion to test lipase activity or blood to test 
haemolytic ability or genetic testing. However, those differential tests are only as accurate in 
predicting true state as the selective step before it is sensitive enough to detect all existing 
isolates of interest. As proved here, AAB is clearly more appropriate.  
To prove this, each medium’s accuracy in predicting the true state of S. aureus presence, with 
confirmation with nuc, was calculated. MSA incorrectly predicted the true state of S. aureus 
9 times (16% error; 84% accurate) and AAB only made 1 incorrect prediction (1.8% error; 
98.2% accuracy). The χ2 value calculated suggested that AAB was significantly more accurate 
(p < 0.01) in predicting the true state of S. aureus from nasal swabs of dogs than MSA. It is 
also more sensitive and more selectively powerful than MSA. More evidence was that MSA 
allowed the growth of fungal colonies (figure 6.3.3, see appendix) in 17.9% of cases, all of 
which were scored as presumptively absent. 10% of cases were false negative as S. aureus 
was in fact present in the sample but remained undetected due to fungal overgrowth.  
Odds Ratio (OR) for MSA was calculated as 0.215 suggesting that MSA is 4.65 (= 0.215-1) 
times more likely to accurately detect the absence of S. aureus than its presence. With the 95% 
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confidence intervals of 0.056 and 0.82 (not spanning across 1.0) this makes this observation 
statistically significant (p < 0.05). This reiterates the poor sensitivity calculated for MSA 
(60.9%), concluding that MSA is not suitable for detecting S. aureus from dog nares as it 
under-represents the data. AAB had an OR of 23.375, suggesting that AAB is 23.375 times 
more likely to accurately detect S. aureus presence than its absence. As the 95% confidence 
intervals did not span across 1.0 (2.81 to 194.18), this observation is considered statistically 
significant (p < 0.05). This reiterates AAB’s poor specificity calculated  
Using the medium used as the baseline factor and the ability to accurately detect S. aureus 
presence (only) as the outcome, an OR of 0.071 is calculated, suggesting that AAB is 14.08 
(= 0.071-1) times more likely to detect S. aureus in dog nare samples than MSA. This is also 
statistically significant (p < 0.05) by the confidence intervals (0.008 and 0.62) and is reiterated 
by the highly significant (p < 0.01) χ2-value calculated previously that suggested the outcomes 
of the two media are significantly different.  
Previous studies comparing media for S. aureus showed very different results in terms of MSA 
accuracy/sensitivity (96.5% as demonstrated by Kim & Oh, 2010, compared to 60.9% as 
demonstrated here), suggesting these sensitivity results are dependent on the type of sample 
used (inoculated food compared to environmental dog nare samples). This proves that the 
context of the sample is required just as much consideration when making the choice of what 
isolation medium to use as the organism of interest.  
Many studies have included mannitol salt agar as the only selective medium for the isolation 
of S. aureus from environmental samples, with other media or biochemical tests, like growth 
on Columbia Blood agar or a positive coagulase test as means of differentiation only, not 
selection. Studies by Kottler et al. (2010), Hanselman et al. (2009), Boost et al. (2008) and 
Middleton et al. (2005) used MSA as the selective agent for S. aureus sampled from dog nares 
and all might have underestimated prevalence rates by as much as 60% as a result (MSA 
sensitivity was 60.9%). Here it has been proven that MSA is not reliable to isolate all S. aureus 
present, depending on the competition levels within a sample. With an under-estimation of 
prevalence can come and underestimated risk of a population as a reservoir for disease.  
One limitation to this investigation is that the sample size was possibly too small and retesting 
this hypothesis that MSA is not selectively powerful enough to detect all S. aureus and 
remeasuring the sensitivity of MSA with a greater sample size may draw more insight on the 
reliability of selective media for environmental samples. Also, the microbial competition in 
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the nares of a dog obviously do not represent all cases of swabs from animals as every species 
is host to different niches which they allow for. 
However, the underestimation of by 60% is in close (but not complete) agreement with the 
results seen in Chapter 3 of this dissertation compared to those studies done previously. While 
prevalence rates previously range between 8 and 17% in studies that used MSA, 35.4% was 
detected when using AAB (<50%). However, there are too many uncontrolled variables (year, 
region, sampling criteria, veterinary healthcare standards etc.) between the datasets for this to 
be a guaranteed fact.  
 
3.5.  Conclusions 
For prevalence studies, selective media must carefully be considered depending on the type 
of biological sample that will be used, or data may be underestimated, and particularly for the 
delicate nature of S. aureus in dogs, MSA is not sensitive enough to provide accurate 
population data, allowing for too much microbial competition to mask S. aureus. Potassium 
tellurite media, like AAB, are more suitable for selection but require additional levels of 
differentiation. While nuc testing is always accurate (assuming no contamination), if the 
medium was not able to select for S. aureus present in the sample, genetic methods are of no 
use.  
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CHAPTER 4 
 
ASSESSMENT OF VIRULENCE AND ANTIMICROBIAL RESISTANCE GENES 
AND OBSERVED ANTIMICROBIAL RESISTANCE PATTERNS IN 
STAPHYLOCOCCUS AUREUS ISOLATED FROM DOGS IN DURBAN 
4.1. Abstract 
Dogs can carry pathogenic S. aureus asymptomatically and act as sources for reinfection to 
humans. However, low prevalence of S. aureus in companion animals have caused them to be 
overlooked as potential nurseries for antibiotic resistance. Nasal swabs were taken from 113 
dogs visiting a local Veterinary Hospital in Durban of which 35% were found to carry 
Methicillin Susceptable S. aureus. No cases of Methicillin Resistant S. aureus were observed. 
Prevalence of virulence and antibiotic resistance genes were estimated. Kirby-Bauer Disc 
diffusion was used to detect resistance to 9 classes of antibiotics. The most notable findings 
were 12.5% tetracycline resistance attributable to tetK (12.5% of isolates) and tetM (2.5% of 
isolates) (p < 0.01); 15% of samples carried immune evasion clusters (IEC) carried by βC-ϕ’s; 
7.5% of isolates were linezolid and vancomycin resistant (LR-VRSA) not attributable to 
resistance genes cfr and vanA respectively and were not induced by veterinary practices. This 
is of great concern as LR-VRSA has never been detected before in animals or outside of India 
and it is clear that some isolates are surviving beyond treatment, hidden in reservoir 
populations, like dogs. This is a huge concern for medical and veterinary practices alike. The 
high prevalence of S. aureus and the presence of LR-VRSA conclude that dog populations of 
Durban pose more of a threat as an overlooked reservior for potentially dangerous S. aureus 
than considered before.  
Keywords: Staphylococcus aureus; LR-VRSA; Antibiotic Resistance Genes; Antibiotic Susceptibility; 
Virulence Genes; Dog 
 
4.2. Introduction 
Staphylococcus aureus is a Gram positive, ubiqutous bacterium that can be both commensal 
(of no harm to its host) or pathogenic (disease causing) and will present in 80% of all humans 
throughout their lives (Kluytmans et al., 1997) and is commonly understood to be a zoonotic 
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microbe (Public Health Agency of Canada, 2011). In its virulent or pathogenic form, it can 
cause several diseases with varying severity, as a result of infection such as infective 
endocarditis (infection of the membrane lining the inside of the heart), osteoarticular infections 
(infection of joints), pleuropulmonary infections (infection of the membrane lining the lungs 
and thorax), infections of skin and soft tissue and also severe infections involving internalised 
devices such as catheters, IV drips and other devices (Kluytmans et al, 1997) (Liu, 2009) (Tong 
et al, 2015). It is also widely understood that S. aureus is transmitted between people through 
contact (Koenig et al., 2016) (Jacobs, 2014) which poses a serious threat to healthcare facilities 
such as hospitals and clinics as any strain of S. aureus, especially methicillin-resistant S. aureus 
(MRSA), may be passed on by asymptomatic staff and visitors to ill or even immuno-
compromised patients.  
There is some uncertainty about the rates of transfer of S. aureus from dogs to humans and 
humans to dogs. A cross-sectional study done by Boost et al., (2008) showed that there is 
definitely transfer between owner and dog. However, it was shown that there was a high 
association of transfer between pet and owner and whether the owner worked in healthcare, 
suggesting that human to dog transfer is more likely. However, there is still potential risk to 
humans as a number of other cases (Manian, 2003; van Duijkeren et al., 2005) found that the 
family dog was a source of reinfection to immuno-compromised individuals who with multiple 
rounds of antibiotic treatment, continued to become reinfected with MRSA. It was only after 
the dogs had undergone treatment did the reinfections cease.  
Virulence in S. aureus is generally tailored to human immune systems (Boost et al., 2008) and 
as such virulent strains can remain asymptomatic in carrier populations of other species (such 
as dogs). Unfortunately, S. aureus has demonstrated resistance to all antibiotic classes used 
against it, acquisition of such caused by changes in its genetic code, either by mutations caused 
by over-exposure to the antibiotics or by acquiring whole resistance genes via horizontal gene 
transfer (Leclercq, 2002; Campion et al., 2004; Courvalin, 2006; Yoon et al., 2008; Ramirez 
& Tolmasky, 2010; Tsubakishita et al., 2010; Endimiani et al., 2011; Liu et al., 2011; Lim et 
al., 2012; Long et al., 2014; Banik et al., 2015). With cases of Multi Drug Resistant S. aureus 
on the rise (Hiramatsu et al., 2014), it is important to assess the prevalence of virulent, resistant 
S. aureus in asymptomatic carriers, especially those like dogs which are in constant contact 
with humans and especially in countries like South Africa which have high rates of immuno-
compromised individuals due to diseases such as HIV, AIDS and others like diabetes (Pillay 
et al., 2016).   
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The purpose of this study was to detect the presence of antibiotic resistant genes and other 
virulence genes as well as the antibiotic susceptibility profiles of isolates, thus assessing the 
risk dogs, as a population, can have as carriers for S. aureus.  
 
4.3.  Materials and Methods 
Sample collection 
Between October 2016 and June 2017, samples were taken from 113 dogs (100 pets in for 
various degrees of veterinary care, 13 were strays left with the clinic to undergo primary care 
in order to bring the animals to adoption appropriate health) housed at a veterinary hospital 
located in Westville, Durban, which caters to pets from inland Durban between Berea and 
Pinetown. Samples were from the nares or any lesions present on the animal’s body. They were 
collected using sterile cotton swabs dipped in autoclaved deionised water, then just the bud of 
the swab was placed in a sterile 15ml  For safety: all animals were handled by veterinary staff. 
Animals infected with other severe zoonotic diseases as well as parvovirus were not sampled.  
Enrichment 
Into each 15ml tube, 5ml of autoclaved peptone water was added and incubated at 37°C for 18-
24hrs before selection.  
Selection 
Sigma-Aldrich’s HiCromeTM Aureus Agar Base (AAB) supplemented with the equivalent of 
3.5% potassium tellurite was used in place of the traditional Mannitol Salt Agar as it is more 
suitable for environmental samples and is more effective at limiting the growth of fungal spores 
likely to be picked up on a nare’s swab. Onto 60mm plates of AAB, 100µl of peptone water 
culture was spread plated and then incubated at 37°C for 18-24hrs. If plates were overgrown, 
a second spread plate was performed using a 10-1 or 10-2 dilution of peptone water, as necessary. 
Very dark black colonies were picked up and isolated on a second 60mm AAB plate using the 
4-way streak method and then incubated at 37°C for 36-48hrs (the extended incubation time 
was to allow for a greater cell mass of any slower growing MRSA isolates).  
DNA isolation 
Individual colonies from the 4-way streak plates were picked up using an inoculation loop and 
broken up into 500µl sterile water at 4°C. Then added was 500µl of 24:1 chloroform and 
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isoamyl alcohol. Tubes were vortexed and centrifuged at 10000xg for 5 min. Approximately 
350 to 400µl of the top aqueous layer was removed and placed into a new tube where it could 
be stored at -20°C for up to 2 months or 5 freeze-thaw cycles (Ruiz-Barba et al., 2005).  
PCR detection of relevant genes 
Listed below in table 4.1 are the primers used for the detection of each gene or gene set. Only 
isolates positive for the thermonuclease gene nuc were tested for the presence of virulence and 
antibiotic resistance genes and susceptibility to antibiotics. All samples were run against a 
negative water control and a neutral species control using S. aureus strain ATCC 25923.  
Table 4.1: Primers used in this study for antibiotic resistance and virulence genes in 
conventional PCR 
Target gene Primer sequence Product size Reference  
nuc F: GCGATTGATGGTGATACGGTT 
R: AGCCAAGCCTTGACGAACTAAAGC 
270 Brakstad et 
al., 1992 
mecA F: AAAATCGATGGTAAAGGTTGGC 
R: AGTTCTGCAGTACCGGATTTG 
310 Ghanbari et 
al., 2016 
Cfr (hot 
start) 
F: TGAAGTATAAAGCAGGTTGGGAGTCA 
R: ACCATATAATTGACCACAAGCAGC 
746 Kehrenberg 
& Schwarz, 
2006 
ermA* F: GTTCAAGAACAATCAATACAGAG 
R: GGATCAGGAAAAGGACATTTTAC 
421 
Ghanbari et 
al., 2016 
ermB* F: CCGTTTACGAAATTGGAACAGGTAAA 
GGGC 
R: GAATCGAGACTTGAGTGTGC 
359 
ermC* F: GCTAATATTGTTTAAATCGTCAATTCC 
R: GGATCAGGAAAAGGACATTTTAC 
572 
tetK F: TATTTTGGCTTTGTATTCTTTCAT 
R: GCTATACCTGTTCCCTCTGATAA 
1159 Trzcinski et 
al., 2000 
tetM F: ACAGAAAGCTTATTATATAAC 
R: TGGCGTGTCTATGATGTTCAC 
171 Aminov et 
al., 2001 
vanA F: GGGAAAACGACAATTGC 
R: GTACAATGCGGCCGTTA 
732 Dukta-Malin 
et al., 1995 
fnbA F: GATACAAACCCAGGTGGTGG 
R: TGTGCTTGACCATGCTCTTC 
191 
Mongodin et 
al., 2002 fnbB F: GGAGCGGCCTCAGTATTCTT 
R: AGTTGATGTCGCGCTGTATG 
201 
hlb F: GTGCACTTACTGACAATAGTGC 
R: GTTGATGAGTAGCTACCTTCAGT 
309 Moraveji et 
al., 2014 
* Genes are in a multiplex reaction 
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In each reaction, 12.5µl of ThermoFisher’s DreamTaq® Green PCR master mix (2x) or 
Promega’s GoTaq® Hot Start Green master mix (2x) (as indicated) was used with 4µl of the 
extracted DNA supernatant. Primers synthesised by Inqaba Biotech were used in the 
concentrations mentioned below and the reactions were made up to 25µl using sterile nuclease 
free water. References for these conditions are provided in table 4.1. Each primer was used in 
the following concentration: 4µM for nuc and mecA; 3µM for ermA-C; 1.25µM for tetM and 
vanA; 1µM for cfr, fnbA, fnbB and hlb; and 0.5µM for tetK. Cycling conditions for nuc were 
initial 94°C for 4 minutes, then 40 cycles of 94°C for 1 minute, 56.6°C for 30 seconds and 
72°C for 90 seconds and then a final 72°C for 3 minutes and 30 seconds. For mecA: initial 94°C 
for 4 minutes, then 40 cycles of 94°C for 30 seconds, 55°C for 30 seconds and 72°C for 1 
minute and then a final 72°C for 5 minutes. For cfr: initial 94°C for 4 minutes, then 34 cycles 
of 94°C for 1 minute, 48°C for 2 minutes and 72°C for 3 minutes and then a final 72°C for 7 
minutes. For ermA-C: initial 94°C for 10 minutes, then 35 cycles of 94°C for 30 seconds, 53°C 
for 30 seconds and 72°C for 1 minute and then a final 72°C for 10 minutes. For tetK: initial 
94°C for 4 minutes, then 35 cycles of 94°C for 1 minute, 50°C for 1 minute and 72°C for 90 
seconds and then a final 72°C for 5 minutes. For tetM: initial 94°C for 5 minutes, then 30 cycles 
of 94°C for 30 seconds, 55°C for 30 seconds and 72°C for 30 seconds and then a final 72°C 
for 7 minutes. For vanA: initial 94°C for 2 minutes, then 30 cycles of 94°C for 1 minute, 54°C 
for 1 minute and 72°C for 1 minute and then a final 72°C for 10 minutes. For fnbA and fnbB: 
initial 94°C for 3 minutes, then 30 cycles of 94°C for 30 seconds, 55°C for 30 seconds and 
72°C for 30 seconds and then a final 72°C for 7 minutes. For hlb: initial 94°C for 7 minutes, 
then 35 cycles of 94°C for 1 minute, 58°C for 1 minute and 72°C for 1 minute and then a final 
72°C for 7 minutes. 
 
Gel electrophoresis 
All products were run through 1.5% agarose gels stained with ethidium bromide at 80V until 
the loading dye provided by the master mix was ~1cm from the bottom. A representative image 
is provided below (Figure 4.1) 
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Figure 4.1: Virulence and Antibiotic resistance genes detected in S. 
aureus. (Lanes: 1 – 100bp ladder; 2 – 50bp ladder; 3 – nuc; 4 – hlb; 5 – 
fnbA; 6 – fnbB; 7 – tetK; 8 – tetM; 9 – vanA) 
 
Antibiotic susceptibility 
Susceptibility was tested using the Kirby-Bauer Disc Diffusion method. Samples were grown 
in Brain Heart Infusion broth overnight at 37°C and then adjusted to the 0.5 McFarland 
standard at 600nm. 100µl of broth was spread plated onto 10mm plates of Mueller-Hinton 
Agar, onto which 5 antibiotic discs were placed (2 plates needed to for all 10 antibiotics). 
Clindamycin and Erythromycin discs were placed no more than 15mm apart so to test for 
inductive resistance to clindamycin. All other discs were placed 25mm apart and away from 
the edge (Figure 6.1 and 6.2 in the appendix). Concentrations of antibiotics used are given in 
table 4.2 below. Despite vancomycin disc testing not being recommended by the Clinical and 
Laboratory Standards Institute, teicoplanin accurately represents vancomycin, as in S. aureus 
resistance is controlled by the same genes (CLSI, 2015). Here, they have been used in 
conjunction with each other.   
 
 
 
250bp 
500bp 
1kbp 
270bp 
309bp 
191bp 201bp 
718bp 
171bp 
732bp 
1 2 3 4 5 6 7 8 9
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Table 4.2: Antibiotic discs used in this study 
Antibiotic Name Antibiotic Class Disc Content (µg) 
Cefoxatin Cephamycin 30 
Ceftoroline Cephalosporin 30 
Ciprofloxacin Fluoroquinolone 5 
Clindamycin Lincosamide 2 
Erythromycin Macrolide 15 
Gentamicin Aminoglycoside 10 
Linezolid Oxazolidinone 30 
Teicoplanin Glycopeptide 30 
Tetracycline Tetracycline 30 
Vancomycin Glycopeptide 5 
 
Statistical Analyses 
All statistical analyses were done using IBM® SPSS® Statistics, version 24. Correlation 
analyses using the Pearson’s coefficient were conducted between genes detected and between 
genes and resistance profiles observed. Significant values were considered at the 95% 
confidence level (two-tailed) and highly significant values were considered at the 99% 
confidence level (two-tailed). All genes or antibiotic profiles with unanimous results were 
excluded from the correlation analysis.  
 
4.4.  Results and Discussion 
Part 1: Prevalence  
Out of 113 dogs sampled, 40 (35.4%) were positive for S. aureus. This is substantially higher 
that previous studies have indicated: 12.5% by Tarazi et al., (2015); 8.8% by Boost et al., 
(2008); 8.25% by Kottler et al., (2010). However, it is not clear if this is due to sampling biases 
(this study only used animals from one clinic, i.e. the clinic itself could be a source of infection, 
while other studies sampled from unrelated locations) or due to isolation procedures (this study 
used an isolation technique more appropriate for environmental samples while all others 
utilised mannitol salt agar (see chapter 4)).  
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Virulence 
Table 4.3, shows the count of samples which tested positive or negative for each virulence 
gene.  
Table 4.3: Presence and absence of virulence genes tested in studied samples 
Gene Present(%) Absent(%) 
hlb 34(85) 6(15) 
fnbA 40(100) 0(0) 
fnbB 40(100) 0(0) 
 
Under normal circumstances, hlb should be detected in all S. aureus isolates. However, βC-φ 
(β-haemolysin converting bacteriophages) will splice themselves into the host’s genome at a 
site that falls within this gene, interrupting the hlb gene. The majority of these prophages carry 
variations of the immune evasion cluster. In this population, 15% of samples are most probably 
carrying other virulence genes in the form of the immune evasion cluster (scn, sak, chp, sea 
and sep). It is difficult to compare this prevalence rate with other studies as there are no other 
studies which have measured this in strains isolated from dogs. However, van Wamel et al., 
(2006) detected 90% of clinically isolated strains (MRSA and MSSA alike) were carrying IEC 
clusters (all hlb negative samples had an IEC), while Cuny et al., (2015) detected 73% from 
MSSA alone from a much smaller sample size (n=15) and only from S. aureus strain CC398. 
From livestock associated MRSA (LA-MRSA) isolated from horses, they detected 6% IEC 
prevalence and in clinical MRSA 19%, all from S. aureus CC398 isolates. There is no data for 
generalised IEC prevalence in S. aureus. However, the data from this investigation still 
suggests that IEC virulence is present in dog populations and can pose a risk to humans who 
may contract S. aureus from their pets.  
The genes fnbA and fnbB are in all isolated samples. This differs from numerous studies which 
suggest varied prevalence rates for these 2 genes. An Indian paper reported 85.5% rate for fnbA 
in clinical S. aureus isolates (Bhatty et al., 2013), whilst an Iranian paper reported 82.2% of 
MRSA isolates carried fnbA and 46.7% carried fnbB (Mirzaee et al., 2015). A second Iranian 
paper detected 56% and 46% fnbA and fnbB, respectively in MSSA clinical samples and higher 
rates (64% and 51%) in MRSA isolates (Ghasemian et al., 2016).These studies suggested 
varying fnbA rates but almost aggreable fnbB rates. Both completely disagree with the findings 
of this study. The variations seen are most probably due to the ancestry of S. aureus strains in 
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each region. This means that the dog populations of Durban carry highly virulent forms of S. 
aureus commonly.  
 
Resistance Profiles 
Table 4.4.1: Presence and absence of antibiotic resistance genes tested in studied samples 
(excluded genes had 100% absent cases) 
Gene Present(%) Absent(%) 
tetK 5(12.5) 35(87.5) 
tetM 1(2.5) 39(97.5) 
vanA 1(2.5) 39(97.5) 
 
Table 4.4.2: Samples with observed resistance (excluded antibiotics had 100% susceptibility)  
Antibiotic Susceptible(%) Intermediate(%) Resistant(%) Total 
Linezolid 37(92.5) 0 3(7.5) 40 
Tetracycline 34(85) 1(2.5) 5(12.5) 40 
Vancomycin/Teichoplanin 37(92.5) 0 3(7.5) 40 
 
Amongst the 40 isolates, no β-lactam resistance, i.e. methicillin or ceftaroline resistance was 
observed with no cases of mecA presence either (the causative for both resistance mechanisms). 
This is not in agreement with numerous studies carried out over the last 20 or so years, these 
studies stating prevalence rates between less than 1% and as much as 50% (Iowa State 
University, 2016; Reddy et al., 2016; Boost et al., 2008; Duquette & Nuttal, 2004). However, 
the majority of these studies demonstrate sampling biases, which prevent their data being 
comparible to this data, due to sampling criteria used, for example, Reddy et al., (2016) only 
sampled from dogs which suffered from recurrent pyodermic infections. Another recent study 
that does agree with 0% MRSA or mecA only sampled 8 S. aureus strains and thus 0% MRSA 
or mecA cannot accurately represent prevalence within the population sampled (Daley et al., 
2016). Considering the criteria for sampling in this project included but did not distinguish 
between animals at risk of S. aureus carriage (such as postoperative pets, immuno-
compromised individuals, individuals that had lengthly stays at veterinary hospitals etc.), it is 
not fair to assume that the data accurately represents general prevalence rates in all dogs in 
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Durban, as the population ranges in the 100 000’s and a sample size of little over 100 
individuals may not detect MRSA if its actual prevalence is less than 1% of less than 40% of 
the population of dogs. However, what can be interpreted from this data is that, regionally, the 
dogs of Durban are not at any concernable risk of MRSA contamination and as a result should 
not be considered a reservoir for MRSA infection in humans.  
Tetracycline resistance was found in 15% (2.5% intermediate, 12.5% absolute resistance) of 
isolates with all cases, except the intermediate case, being attributable to either tetK or tetM. 
One isolate was found to have carry tetK but did not express resistance. Higher rates of 
tetracycline resistance compared to other antibiotics is not surprising as tetracycline used to be 
the first line of antibiotic used for general respiratory infections in veterinary care (Guardabassi 
et al., 2004). It has since been made a second choice antibiotic due to its wide-spreading 
resistance (Maaland et al., 2013). There are very few recent studies (after 2010) that look at 
prevalence rates in dogs with S. aureus specifically (none in Africa). Boost et al., (2008) 
reported 29% resistance to tetracycline in S. aureus isolated from dogs, but incidence of tetK 
and tetM were not measured. S. pseudointermedius, the most prevalent Staphylococcal 
pathogen in dogs (Werckenthin et al., 2001) is capable of sharing resistance with co-infecting 
S. aureus, and such related resistance prevalence is not impossible. A study by Rubin et al., 
(2011) showed 34% of S. pseudointermedius carried by dogs exhibited resistance to 
tetracycline, in agreement to the results seen in the study by Boost et al., (2008). In conclusion, 
tetracycline resistance observed was not unexpected but the lower levels observed as compared 
to those in papers of 10 years previous to this study, are possibly due to the awareness of 
growing incidence of tetracycline resistance and the subsequent restrictive use in veterinary 
care.  
Vancomycin resistance was observed in 3 cases (7.5%), all of which were also resistant to 
linezolid (Figure 6.2). This is relatively disturbing as linezolid is the first choice of antibiotic 
for use against vancomycin (glycopeptide) resistant strains of S. aureus (Balkhair et al., 2010; 
Loomba et al., 2010). While there have been reports of linezolid resistant Enterococci (LRE) 
in India, China and the UK (Auckland et al., 2002; Kumar et al., 2014; Tian et al., 2014) there 
a only a few isolated incidents of linezolid resistant S. aureus (LRSA) in cystic fibrosis patients 
that were exposed to linezolid for extended periods, on multiple occasions (Gu et al., 2013; 
Endimiani et al., 2011). Only very recently have LR-VRE been identified (Gupta, 2016), along 
with the emergence of LR-VRSA. Until now, no cases LR-VRSA have been reported outside 
of India, (Azhar et al., 2017; Kumar, 2016; Singh et al., 2014). This includes veterinary studies 
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as well. All strains were hospital acquired strains and are directly associated with antibiotic 
pressure (Mandal et al., 2017). Upon further communication with the head veterinarian at the 
Veterinary Hospital in Westville, it was deduced that these dual resistant strains had to have 
originated from a human patient, as linezolid has never been used on veterinary patients at that 
hospital due to the ethical implications it poses on humans, thus reaffirming the overlooked 
potential companion animals have as a reservoir for reinfection of S. aureus in humans.  
As Kwa-Zulu Natal has the largest population of Indians outside of India, it is most probable 
that some of these strains were brought over by individuals visiting their families and that is 
why South Africa has seen this resistance before anyone else. It must be reitterated that this 
prevalence rate most likely does not represent the whole Durban population of dogs due to 
sampling biases, and the value of 7.5% rate of LR-VRSA relates to this data only, until such 
time as further studies with larger sample sizes of a more diverse nature are carried out. 
However, the shear existance of these strains, regardless of their prevalence should not be taken 
lightly. The presence of cfr (the only form of linezolid resistance that is transferable 
horizonatally) was not detected in these isolates suggesting mechanisms derived from 
mutations caused by over exposure to linezolid (Gu et al., 2012). None of the isolates carried 
vanA, suggesting that another van gene was present, not detected by the used PCR protocol. 
However, vanA was found in 1 sample that did not express vancomycin resistance (2.5%). This 
agrees with the findings of Azhar et al., (2017) who noted 3.1% of MSSA were vancomycin 
resistant. They too observed some non-vanA associated vancomycin resistance (22% of 
vancomycin resistant isolates).  
Part 2: Correlation 
Below in table 4.5 are the counts of various factor combinations observed in this study. Factors 
in italics indicate genes present (note: “iec” is not a gene but represents the presence of IEC as 
proved by a lack of and intact hlb gene). Factors in uppercase represent resistance observed. 
Resistance with a ‘*’ represent intermediate resistance. 
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Table 4.5: Factor profiles observed  
Profiles Cases Observed 
None 22 
iec 4 
iec, LZD, VA 2 
LZD, VA 1 
vanA 1 
tetK, TE 4 
tetK 1 
tetM, TE 1 
DA*, TE* 1 
CIP* 1 
CN* 1 
E* 1 
 
A Pearson’s 2-tailed correlation detected significant relationships between factors (note: 
vancomycin/teicoplanin and linezolid resistance were considered a single factor (LZD-VA) as 
all instances were found in the same 3 samples). The most significant relationships (p < 0.01) 
were between hlb and LZD-VA, tetK and TE, and tetM and TE. No other significant 
relationships were observed. Relationships between TE and the two tet genes is not surprising 
as there was no incidence of tetracycline resistance not attributable to either tet gene. The 
relationship between hlb and LZD-VA should be considered with caution, as 3 individuals with 
only 2 with identical profiles, while statistically significant, do not necessarily represent what 
would be observed in a larger population.  
 
4.5.  Conclusions 
The major limitation of this investigation was that the sample size was not appropriately large 
enough for the large number of factors being tested (40 positive samples being tested against 
10 genetic and 9 antimicrobial factors) and did not span enough sample sources to give a clear 
indication of the reliability of the results seen as good representation of the total population of 
dogs in Durban. However, some notable findings were made. Even from similar type studies 
with similar sampling biases, a substantially larger number of S. aureus isolates were detected 
than previously stated in literature. This already suggests that dogs as a population are most 
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likely underestimated as a potential reservoir for S. aureus. This is motivation to draw up a 
meta-analysis which tests the statistical contributions that varying sampling factors may have 
on a dataset in this context (household vs clinic; surfaces, staff and tools in clinics; etc). As it 
stands, this data does suggest that dogs may be a greater reservoir for S. aureus for human 
infection than previously anticipated. 
The detection of LR-VRSA reinforces this fact and also casts a very long shadow across the 
future of antibiotics. Up until now, even though no clinical cases of LR-VRSA have been 
observed outside of India, it is clear that some isolates are surviving beyond treatment, hidden 
in reservoir populations, like dogs. This is a huge concern for medical and veterinary practices 
alike. When patients are infected with already resistant species and are onto their second round 
of antibiotics, they should be isolated until the infection has been completely eliminated. This 
will reduce the possibilities of instances of isolates developing second resistances and surviving 
undetected.  
Apart from this, campaigns should be started as updates to current measures in place to 
eduacate animal owners and veterinary staff about the risks of cross infections with this 
microbe specifically. Any registered breeders or adoption facilities should be required by law 
to inform new animal owners of the risks involved with cross-infenctions of S. aureus and the 
measures of prevention that can be taken. Booklets can then be handed to the new pet owners 
to take home for reference. Medical doctors and veternary specialists should consider pooling 
information of households by monitoring carrier status of both humans and animals living 
together biannualy (to monitor changes over flu season) and then appropriately sterilise 
individuals if status is found to be positive.  
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CHAPTER 5: GENERAL CONCLUSIONS 
 
Apart from, possibly, the anti-vaccination movement, there has been no doubt that the rise of 
multidrug resistant bacteria is the greatest threat to modern medicine to date, with cases of 
multidrug resistant S. aureus being reported all over the globe (Barua et al., 2017; Carroll et 
al., 2017; Deyno et al., 2017; Saba et al., 2017). While the major contributing factor is poor 
antibiotic etiquette on both the patient and doctors’ sides, another major and overlooked factor 
is general hygiene practices. While no-one denies its importance for preventing the spread of 
dangerous pathogens, not many people commit to these practices vigorously, resulting in many 
pathogens enduring and remaining under the radar until someone becomes sick. Ultimately, 
this project aimed to gauge the extent of “under-the-radar” S. aureus in a population that is 
otherwise overlooked due to the fact that S. aureus remains asymptomatic in dogs, except in 
instances of co-infection. This project tested the extent of underestimating dogs as reservoir 
populations for S. aureus in two parts: by detecting isolates within the population and 
determining their pathogenic factors (virulence and antibiotic resistance) as a result of human 
interaction; and testing the methods previously employed to carry out the first part. Both 
yielded significant and agreeable findings. 
 
5.1.  Significant Findings 
The prevalence study yielded 12.5% tetracycline resistance attributable to tetK (12.5% of 
isolates) and tetM (2.5% of isolates) (p < 0.01); 15% of samples carried immune evasion 
clusters (IEC) carried by βC-ϕ’s; 7.5% of isolates were linezolid and vancomycin resistant (LR-
VRSA) not attributable to resistance genes cfr and vanA respectively and were not induced by 
veterinary practices. Tetracycline resistance can be attributable, in some part, to veterinary 
practice as it is the first drug of choice against Gram-positive infections and are often 
administered in a preventative manner for fresh wounds and are second choice for respiritory 
infections (Maaland et al., 2013; Guardabassi et al., 2004). However, vancomycin and linezolid 
resistance (especially co-resistance) are definitely not associated with veterinary practices as 
veterinary medicine does not employ these last resort drugs which are both dangerous for the 
health of the animals and pose an unethical risk to human medicine. Thus, these strains were 
passed from human to animal, where they have remained asymptomatic and under-the-radar. 
The most troublesome information is that these strains have not been seen outside of India up 
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until now, suggesting that human individuals (probably owners of the animals) had contact 
with persons from India, carrying these strains. The large population of Indian decendants in 
Durban, Kwa-Zulu Natal, makes a good case for the potential bridge made for this pathogen 
that travels across the globe. This finding (LR-VRSA) in particular, and the high prevalence 
rate of S. aureus (35%) suggest that dogs as a popultion have been grossly underestimated as 
potential reservoir for S. aureus.  
This is reitterated by the findings of the second part of this study which demonstrated that the 
methods which use MSA as the selective step for isolating S. aureus from dog nares 
specifically, when used to determine prevalence rates, is unreliable (not sensitve or accurate 
enough and is prone to type I errors due to poor selective power: “false false positives) and has 
possibly been underestimating the prevalence rates in studies which it was employed. AAB 
proved 14 times more likely to correctly detect S. aureus than MSA, in this context. This is an 
incredibly important finding as most studies up until now, some which are are still used as the 
standard for comparison (studies such as those done by Boost et al., 2008), all employed MSA 
as the method of isolation. The combination of results conclude that there has been a great 
underestimation of the potential dog populations pose as a reservoir for S. aureus and that this 
underestimation most probably has caused the casual manner in which humans acknowledge 
their hygiene in association with their pets.  
 
5.2.  Limitations 
The greatest limitation seen in both parts of this study was that the sample population was not 
large or diverse enough to assure with 100% confidence, that these prevalence rates accurately 
represent the population of Durban pet dogs and the traits observed were definitely due to 
medical or veterinary practices (as discussed above). However, despite the small sample size, 
highly significant results (p < 0.01) were attained from the second study suggesting that, 
regardless of the sample size, it was definite that AAB was more accurate in this biological 
context (swabs from dog nares) than MSA. Precise error rates may not be truly representative 
and but testing a larger population size would make the results observed more significant.  
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5.3.  Future Recommendations 
With regard to this project and those that may stem from it, a larger and more diverse sample 
population must be used, including animals from different socio-economic areas, from 
households instead of clinics, strays and surrendered animals in organised facilities (strays that 
otherwise have no human contact may be safety risk for individuals involved and are unlikely 
to yield much valuable information as dog to dog S. aureus transferance is extremely rare) and 
should include potential erroneous factors (factors that skew the observed rates) such as testing 
the humans that are in contact with the animals (clinic staff, owners, individuals involved in 
the study) and the environments in which they are kept (cages, surfaces in clinics, x-ray 
equipment etc.). A study of that magnituted could make a powerful statistical argument for any 
significant findings (prevalence or correlation) that may be observed.  
With regard to the general population and both medical and veterinary practices, these findings 
suggest that more attention needs to be paid to pets as reservoir populations of pathogens like 
S. aureus. Epidemiologically, these populations have been overlooked when surveillance of 
them has proven useful (in this study) in predicting the movement of resistant isolates on a 
global scale. Also, on a more individual civilian scale, the importance of maintaining certain 
hygiene practices with ones animals must be impressed upon as it is clear that forgoing such 
measures could be detrimental to the health of many people. Reminders to sterilise ones hands 
before leaving hospitals, clinics or doctors’ rooms should be intalled and the general public, 
pet owners specifically, should be educated on the risks that not following these hygiene 
practices may have. It cannot be the responsibility of the medical community (a tiny part of the 
population) to maintain and remedy pathogens without the informed co-operation of the 
general population.  
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APPENDIX 
 
Figures 6.1.1 and 6.1.2: Orientation of discs used for antibiotic susceptibility testing with a 
susceptible S. aureus control. (Plate 1: CIP – ciprofloxacin; DA – Clindamycin; E – 
Erythromycin; CN – Gentamicin; TE – Tetracycline. Plate 2: FOX – Cefoxitin; CPT – 
Ceftaroline; LZD – Linezolid; TEC – Teicoplanin; VA – Vancomycin) 
 
Figure 6.2: Observed resistance profile for LR-VRSA samples (FOX – Cefoxitin; CPT – 
Ceftaroline; LZD – Linezolid; TEC – Teicoplanin; VA – Vancomycin) 
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Figure 6.3.1 and 6.3.2: Presumptive S. aureus colony morphology on MSA (Plate 1) and AAB 
(Plate 2) 
 
Figure 6.3.3: MSA plate showing mannitol reducing fungal colonies 
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